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Anton Bruil, Tom Beugeling, Jan Feijen, and Willem G. van Aken 
C ONVINCING evidence exists that blood transfusions are associated with deleterious 
effects caused by residual leukocytes in blood and 
blood components. These side effects include al- 
loimmunization to histocompatibility antigens, 
transmission of viruses, immunosuppression a d 
graft-versus-host disease (GVHD). Leukocyte de- 
pletion of blood components may prevent or ame- 
liorate some of these harmful effects. Among the 
various methods to remove or reduce leukocytes in 
blood components, filters have been shown to be 
most efficient. However, the mechanism of leuko- 
cyte depletion by such filters is not completely 
understood, which limits the development of im- 
proved, cost-effective, and clinically applicable 
filter materials. 
The aim of this review article is to discuss the 
development of leukocyte filters, the various 
mechanisms of leukocyte filtration, and mathemat- 
ical models to describe the process of leukocyte 
filtration. 
CLINICAL APPLICATION OF 
LEU KOCYTE-DEPLETED 
BLOOD COMPONENTS 
The prophylactic use of red blood cell transfu- 
sions containing fewer than 5 x 10 6 leukocytes per 
transfused unit has been shown to prevent or delay 
the acquisition of nonhemolytic febrile transfusion 
reactions (NHFTR) in patients who are transfusion 
dependent.~-3 Leukodepletion is also an effective 
method to abolish recurrent NHFTR to red blood 
cell concentrates. NHFTR are preceded by the for- 
mation of antibodies directed against HLA anti- 
gens on donor cells. HLA immunization may also 
be the cause of refractoriness to random donor 
platelet ransfusions. 4-6 However, the evidence 
that leukocyte depletion in transfused components 
can prevent the development of a refractory state is 
limited. 7 Newly diagnosed patients with severe 
aplastic anemia, who are potential recipients of 
bone marrow transplants, are candidates for leu- 
kodepleted red blood cell and platelet concen- 
trates. Once such patients become sensitized to 
HLA antigens, there is a higher isk of graft rejec- 
tion. 
Viruses that are cell-associated such as cyto- 
megalovirus (CMV), Epstein-Barr virus (EBV), 
and human T-cell lymphotropic viruses (HTLV) 
may be transmitted by blood transfusion. The re- 
moval of leukocytes from blood is effective in re- 
ducing the risk of leukocyte-associated virus trans- 
mission. 8-1~ Leukodepletion of red blood cell and 
platelet concentrates to less than 5 x 10 6 cells per 
unit has been shown to be effective in preventing 
CMV transmission. 11,12 
Although leukocyte reduction through filtration 
has been applied in a variety of other conditions, 
the evidence of clinical benefit awaits further stud- 
ies. Notably, improvements in clinical outcome, in 
terms of morbidity and mortality, have not been 
investigated a equately. The use of leukocyte-poor 
blood components has been recommended to pre- 
vent immune modulation in neonates and surgical 
patients, which might lead to a decreased rate of 
postoperative infection. 13 Similarly, cancer pa- 
tients undergoing surgery might benefit from leu- 
kodepletion of blood components because immu- 
nomodulation by transfusion is prevented and 
cancer ecurrence would be lower. The indications 
for leukodepletion of blood components are at 
present classified as only possible, until more de- 
finitive studies have been performed. 
GVHD in patients undergoing organ transplan- 
tation can be induced by transfused leukocytes. In 
theory, depletion of leukocytes could be a way to 
prevent this complication. However, gamma- 
irradiation of components has already been shown 
to be effective. TM Removal of leukocytes from 
blood may also prevent the formation of microag- 
gregates. Microaggregates are clumps of degener- 
ating leukocytes, platelets, and fibrin that are 
formed spontaneously during the storage of leuko- 
cytes containing blood. ~5 During cardiopulmonary 
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bypass surgery and massive transfusion, microag- 
gregates may induce the formation of microemboli 
in the patient's pulmonary circulation, which is 
probably associated with a large number of unex- 
plained postoperative r actions uch as acute re- 
spiratory distress yndrome (ARDS). 16-]8 The re- 
moval of microaggregates from stored blood zs and 
the removal of leukocytes from blood before stor- 
age 19'2~ may prevent hese complications. 
Techniques to Prepare Leukocyte-Poor Blood 
A variety of techniques have been developed to 
prepare leukocyte-poor blood components. 21-25 
Although many methodological variations and 
combinations of these techniques exist, five basic 
methods can be distinguished; (1) differential cen- 
trifugation, (2) sedimentation, (3) cell washing, 
(4) freezing and thawing, and (5) filtration. 
Differential centrifugation. Differential cen- 
trifugation was the earliest and is still one of the 
most frequently used techniques for the production 
of leukocyte-poor blood. 21 When blood packs are 
centrifuged, blood cells will sediment according to 
their specific size and density (Table 1). Thus, 
after centrifugation, whole blood can be separated 
into three fractions; (1) packed red blood cell con- 
centrate, (2) cell-free plasma, and (3) a leukocyte- 
and platelet-rich layer (buffy coat) that separates 
plasma from the red blood cell concentrate. By 
removal of the buffy coat approximately 70% to 
90% of the leukocytes can be depleted, with red 
blood cell loss ranging from 10% to 40%. 23,24,44,45 
However, complete separation of the various cel- 
lular components cannot be obtained by centrifu- 
gation. The depletion of leukocytes can be im- 
proved by a second centrifugation step after the 
addition of an isotonic saline solution to the packed 
red blood cells, but this procedure causes a sub- 
stantial loss of red cells. 26 
The widespread use of centrifugation for the 
preparation of leukocyte-poor blood can thus be 
attributed to its simplicity, adaptability, production 
efficiency, and ability for large-scale production. 
Shortcomings of the technique are the limited re- 
moval of leukocytes, the appreciable loss of red 
blood cells, and the relatively long processing 
time.21, 25 
Sedimentation. Spontaneous sedimentation of
red blood cells, ie, without he use of centrifuga- 
tion, can be enhanced by the addition of agents that 
promote the formation of red blood cell aggre- 
gates, known as rouleaux formation. 21 High mo- 
lecular weight dextran has been frequently used for 
this purpose. 4s-47 After sedimentation, the super- 
natant and the buffy coat can be removed, resulting 
in the depletion of more than 80% of the leuko- 
cytes. The loss of red blood cells is very low com- 
pared with other methods. Eventually, red blood 
cell concentrates can be subjected to a second sed- 
imentation procedure to improve the removal of 
residual leukocytes without significant loss of red 
blood cells. 46'47 
The advantages of dextran sedimentation are its 
low cost and the independence from special equip- 
ment. However, the technique is time consuming, 
labor intensive, and when performed in an open 
system, susceptible to the risk of bacterial contam- 
ination, thus shortening the expiration date of the 
product. This technique is no longer widely 
used. 19 
Table 1. Concentration and Physical Properties of Human Blood Cells 
Concentration* DensiWt Diameter$ 
Ceil Types (p.L 1) (g/cm 3) (i,Lrn) Deformabilityw Adhesiveness II 
Erythrocytes 4,000,000-6,000,000 1.090-1.110 7-8 eete 9 
Platelets 150,000-400,000 1.054-1.062 2-3 9 eeee 
G ran u I coytes 2,000-6,0 O0 1.080-1.084 5-8 eee eee 
Lymphocytes 1,500-4,000 1.060-1.072 4-8 ee ee 
Monocytes 200-800 1.055-1.062 4-10 ee eeee 
* Blood cell counts in adult whole blood, according to Baker and Silverton. 2s 
1" Blood cell density according to Roos and de Boer. 27 
$ Leukocyte diameters in isotonic salt solution (pH 7.4), measured by transmission electron microscopy (TEM), 2s other cell 
diameters according to Baker and Silverton. 2e 
w Relative deformability of cells (more dots, ie, more deformable), as defined by their ability to passively flow through the pores 
of a Nucleopore filter, z9-35 Deformability of platelets according to Br&nemark and LindstrSm. 3s 
tt Relative adhesiveness of cells to solid surfaces (more dots, ie, more adhesive), arbitrarily classified, and based on various reports 
in which the adhesion of specific blood cells to solid surfaces is compared. 37`43 
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Cell washing. Red blood cell washing com- 
bines differential centrifugation a d continuous di- 
lution of the cells using isotonic saline solution. 25 
A variety of automatic ell washers is currently 
available for this purpose. The centrifugation pro- 
cess in these machines i performed in a disposable 
container of defined size and geometry, which al- 
lows the various blood components obe removed 
in the order of their specific densities. However, 
the separation efficiency is limited by the small 
differences between the densities of the blood cells 
(Table 1). Depending on the process conditions, 
automatic cell washers can remove 70% to 95% of 
the leukocytes from whole blood, whereas the loss 
of red blood cells is approximately 15%. 23,24,48,49 
The major advantage of this method is its effi- 
ciency in removing more than 95% of the plasma 
from whole blood. 48'49 Plasma removal may be 
beneficial in reducing the risk of virus transmis- 
sion. 21 Disadvantages of the method are the high 
cost, the long processing time, the open-system 
handling, and the logistical problems with regard 
to the supply of cellular products. 21 Red blood cell 
washing is therefore used only occasionally for the 
routine preparation of leukocyte-poor blood. 
Freezing and thawing. The freezing method 
was developed originally for the long-term preser- 
vation of red blood cells. To protect hem against 
freezing, a cryoprotective agent, eg, glycerol, 
which is avidly taken up by red blood cells, is 
added to the blood. 5~ On freezing, ice crystals that 
rupture the cell membranes during thawing are 
formed in the leukocytes. The subsequent washing 
procedure removes both glycerol and leukocyte- 
rich stroma. 5~ With this method usually more than 
95% of the leukocytes are removed, whereas red 
blood cell loss is less than 10%. 22-24,52 However, 
it should be noted that red blood cell concentrates 
may contain residual leukocyte fragments that may 
cause the same posttransfusion complications as 
previously described for intact leukocytes. 51
Because of its efficiency in depleting leukocytes 
from blood, the freeze-thaw method has long been 
considered as the optimal method for the prepara- 
tion of leukocyte-poor blood.19'25 However, sev- 
eral logistic difficulties uch as the requirement for 
expensive facilities for the freezing and storage of 
cells, the limited availability of products on a rou- 
tine basis, and the short expiration period because 
of open-system handling have led to the displace- 
ment of this method by other approaches. 
Filtration. Filtration as a means to remove 
leukocytes from blood became routine practice af- 
ter the development of microaggregate filters. Re- 
moving aggregates from blood to prevent forma- 
tion of emboli in recipients after transfusion was 
accomplished with the use of these microaggregate 
filters. 18,53,54 Although originally not intended for 
this purpose, microaggregate filters have been re- 
ported to have an appreciable leukocyte-removal 
capacity. 24'55'56 Over the last decades, microag- 
gregate filtration has evolved into a method to pro- 
duce leukocyte-poor blood. Currently available 
special leukocyte filters do not require microaggre- 
gate formation before filtration, because their 
function is based on differences in deformability 
and adhesiveness between different cells (Table 1). 
These filters generally remove more than 95% of 
the total number of leukocytes in one unit of blood, 
whereas the red blood cell loss typically is less 
than 10% (Table 2). 
Nowadays, leukocyte filtration is the most com- 
monly used method to prepare leukocyte-poor 
blood. The procedure is simple, fast, clinically ef- 
fective, and does not require expensive quip- 
ment. 1.11.12.58 Moreover, the process does not re- 
quire open-system handling, which favors the shelf 
life of the products. Nevertheless, leukocyte filters 
can be further improved by the optimization of 
leukocyte-depletion capacity, red blood cell recov- 
ery, processing time, and cost. 
Development ofLeukocyte Filters 
Filtration as a means to remove leukocytes from 
blood was first described in 1926 by Fleming, who 
used a column filled with cotton wool to prepare 
small quantities of leukocyte-poor blood. 66 In sub- 
sequent years, a number of filters of different ma- 
terials were developed, 16"37 but it took until 1962 
before Greenwalt et al reported a filtration method 
for use in blood bank practice.6V When heparinized 
blood was filtered over columns filled with Orlon 
(Du Pont de Nemours, Geneva, Switzerland), Da- 
cron (Du Pont de Nemours), Teflon (Du Pont de 
Nemours), or nylon fibers, it was found that leu- 
kocyte removal was most effective when nylon fi- 
ber filters were used. With these filters granulo- 
cytes were completely removed, whereas most of 
the lymphocytes were recovered in the filtrate. Al- 
though leukocyte removal was only partial, the in- 
cidence of NHFFR in recipients was significantly 
reduced when granulocyte-poor blood was used for 
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Table 2. Survey of Currently Available Filters to Remove Leukocytes From Blood 
Depletion Recovery 
Trade Name Manufacturer Filter Material WBC (%) RBC (%) References 
Imugard IG500 Terumo, Tokyo, Japan Cotton wool 93-98 85-97 1, 3, 22-24, 56-59 
Cellselect* NPBI, Emmercompascum, The Netherlands Cellulose acetate fiber >99 75-88 3, 57, 60 
Erypur* Organon, Boxtel, The Netherlands Cellulose acetate fiber 96-98 90-99 1, 56, 57, 59, 61 
Miropore Miramed, Mirandole, Italy Cellulose acetate fiber 95-99 >92 3, 58 
Leukoseize Dideco, Mirandole, Italy Cellulose acetate fiber >95 >92 58 
Sepacell R500 Asahi, Tokyo, Japan Polyester fiber 95-98 8-96 3, 57, 58, 60-64 
Optima NPBI, Emmercompascum, The Netherlands Polyester fiber 95-99 86-92 58, 60, 62, 63 
RC100 Pall, Glen Cove, NY Polyester fiber 98-99 75-94 57, 60, 62, 63 
Leukostop Miramed Polyester fiber 95-98 88-92 58, 60 
Leukopakt Travenol, Thetford, UK Nylon fiber 42-54 90-99 22, 56 
Ultipor SQ40S$ Pall Polyester mesh 13-57 93-95 53-56, 65 
4C 2423r Fenwall, Glendale, CA Polyester wool -44  -66  53, 54, 56 
Note: It should be noted the data in columns headed Depletion WBC and Recovery RBC were obtained from different laboratories 
and that different filtration methodologies may have been used. For example, some investigators have filtered whole blood, 
whereas others have used red blood cell concentrates, ie, blood from which plasma and/or buffy coat was removed by centrifu- 
9ation. 
* In some countries, the Cellselect filter is marketed by Organon, The Netherlands, under the trade name Erypur. 
5" The Leukopak filter was originally designed to harvest granulocytes from heparinized blood. 22 
t The Ultipor and 4C 2423 filters were originally designed to remove microaggregates from stored blood, but are known to have 
appreciable leukocyte removal capacity, s5,56 
transfusion. 67 Filtration over nylon fibers later 
evolved into a technique to isolate lymphocytes 
from blood 68 and was also used to purify granulo- 
cytes by a technique known as filtration leukaphe- 
res i s .  69'7~ 
The leukocyte filtration technique was substan- 
tially improved in 1972 by Diepenhorst, who de- 
veloped aprototype leukocyte filter consisting of a 
column filled with tightly packed cotton wool. 71 
Using this filter, more than 95% of all leukocytes 
in whole blood could be removed, whereas red 
blood cell loss was less than 10%. Two years later, 
the first disposable leukocyte filter for routine use 
in blood banks became available. 72 A similar fil- 
ter, the Imugard IG-500 (Terumo Corp, Tokyo, 
Japan), based on the Diepenhorst prototype was 
introduced in 1978. 73 Several clinical studies have 
shown that such filters are effective in the prepa- 
ration of leukocyte-poor blood (Table 2). 
Soon after the introduction of the cotton wool 
fibers, other types consisting of cellulose acetate 
fibers were developed. The replacement of natural 
by synthetic fibers led to less pyrogenic filters 59 
and constant quality of the filter material, 94 result- 
ing in safer products. Cellulose acetate filters are 
still widely used to remove leukocytes. 
More recently, the technology to prepare leuko- 
cyte filters has advanced considerably. The obser- 
vation that leukocyte removal by filters was ac- 
complished, at least in part, by adhesion of cells to 
the filter fibers led to the preparation of filters with 
larger internal surfaces, 75 which can be achieved 
through the use of small-diameter fibers (Fig 1). A 
melt-blowing process, in which a molten polymer 
is cast into fibers by a high-velocity stream of gas 
and collected as a nonwoven web, is used to pre- 
pare webs of fibers with an average fiber diameter 
of less than 2 I, tm. 75'76 Such thin fibers have been 
reported to be more effective for leukocyte deple- 
tion as compared with fibers with a larger diame- 
ter. 77 Current leukocyte filters (Table 2) consist of 
different layers of nonwoven polyester fibers that 
can easily be processed by melt blowing. Polyester 
fiber filters have been shown to be very effective in 
the preparation of leukocyte-poor blood, as is 
shown by the removal of up to 99.9% of leuko- 
cytes. 60'61"78'79 Recently, the development of a fil- 
ter that removes 99.9999% of leukocytes was re- 
ported. 8~ 
Although most currently used leukocyte filters 
show a high efficiency, further optimization is still 
desirable. 61 Filters that can produce red blood cell 
concentrates that are completely free of leukocytes 
have not yet been developed but may be beneficial 
for the various clinical situations discussed previ- 
ously. Another characteristic tobe optimized is the 
filter capacity. Increased leukocyte removal capac- 
ity may lead to a reduced filter size and thus to a 
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Fig 1. Typical example of the 
different diameters of fibers, 
used in (A) traditional cellulose 
acetate fiber filters (Cellselect; 
NPBI) and (B) current polyester 
fiber filters (Optima; NPBI). 
higher yield of purified red blood cells, which is 
desirable for both clinical 1 and logistical pur- 
poses. 23 Filter optimization may also reduce the 
cost and length of filtration and lead to easier fil- 
tration procedures. 1 Overall, leukocyte filtration is 
still a relatively expensive method to prepare leu- 
kocyte-poor blood, as compared with other meth- 
ods such as differential centrifugation and wash- 
ing. 23 Reduction of the processing time is 
advantageous for the rapid provision of leukocyte- 
poor blood 6~ and for the application of filtration 
directly at the bedside. 79 
Thus far, the optimization of filter materials has 
been achieved largely by trial and error. The de- 
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velopment of new filters would benefit from a bet- 
ter understanding of the mechanisms causing leu- 
kocyte depletion. So far, these mechanisms have 
not been studied systematically, although it has 
been suggested by several investigators that leuko- 
cyte filtration is governed by sieving and adhe- 
sion. 21'22'6~ However, the quantitative con- 
tribution of each of these factors has never been 
rigorously investigated. 
LEUKOCYTE FILTRATION MECHANISMS 
Filtration processes are usually divided into 
three categories; urface filtration, cake filtration, 
and depth filtration. 82'83 Surface filtration is the 
process in which particles larger than a given size 
cannot pass through the filter surface, causing a 
complete separation of these particles from the sus- 
pension medium. Because the retained particles 
will rapidly clog the filter, surface filtration is only 
possible when the particle concentration is low. 
During cake filtration the filtered particles form a 
porous layer, a cake, on top of the filter. As long 
as flow through this filter cake is possible, the 
layer itself will contribute to the retention of more 
particles. For depth filtration, the retention of par- 
ticles is not restricted to the filter surface. In gen- 
eral, depth filters have an open porous structure, 
with a wide distribution of pore sizes throughout 
the filter matrix. This specific structure allows the 
retention of particles at any place inside the filter. 
The filtration of leukocytes from blood by 
means of leukocyte filters can be regarded as a 
depth filtration process. 65 Depth filters usually 
consist of a bed with tightly packed granular or 
fibrous material, s4'85 and are most frequently used 
for the purification of waste water s2,84's6'87 and 
gases. 8s Although membranes are often regarded 
as surface filters, 82's9 open cellular foams resem- 
bling membranes have rarely been used for depth 
filtration. 9~ The theory developed to explain the 
mechanism of depth filtration has been almost ex- 
clusively applied for the analysis of deep-bed sand 
filtration.83 The same theory could be used to ex- 
plain leukocyte filtration but this has never been 
reported. 
Several elementary mechanisms are known to 
play a role in the retention of particles in depth 
f i l ters. 86'87'93'94 The mechanisms that are probably 
involved in leukocyte filtration include blocking or 
Fig 2. Schematic diagrams of elementary mechanisms of 
particle retention in depth filters; (A) blocking, (B) bridging, 
(C) interception, either dead end (a), labile (b), or stable (c), 
and (D) adhesion. 
straining, bridging, interception, and adhesion 
(Fig 2). Combinations of the afore-mentioned 
mechanisms may also occur. Blocking may occur 
when the particle size is larger than the diameter of 
the pore that has to be passed. Bridging becomes 
significant at high particle concentrations 95 and oc- 
curs when two or more particles imultaneously 
flow through a relatively large pore and become 
entrapped as an aggregate. Interception is the pro- 
cess in which particles are mechanically trapped at 
filter sites other than small pores. Interception may 
be stable, labile, or occur at dead ends (Fig 2). 
Adhesion of particles to the filter material becomes 
important when the ratio of particle to pore diam- 
eter 93'94 is about 10 -4 to 10-~. When adhesion 
occurs, the action of mechanical forces such as 
gravity, hydrodynamic pressure, or fluid flow is 
not necessarily a prerequisite o retain the particle 
in the filter. Because depth filtration is generally 
concerned with the removal of particles that are 
many times smaller than the pores of the filter, the 
effects of blocking, bridging, and interception are 
often neglected because adhesion is the predomi- 
nant mechanism. 87"96 
An alternative approach to explain depth filtra- 
tion is to distinguish mechanical entrapment (siev- 
ing) from physico-chemical entrapment (adhe- 
sion). The pore size of the filter then determines if 
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sieving becomes important. Based on particle/filter 
dimensions, it has been assumed that sieving oc- 
curs when particles are larger than 30 ~m and that 
adhesion occurs when particles are smaller than 1 
[xm. 85'86 When the particle size is between 1 and 
30 Ixm, as occurs during leukocyte filtration, both 
processes likely occur simultaneously. 
Cell Sieving 
Because blood cells differ both in size and de- 
formability, sieving should be considered as a pos- 
sible mechanism in the filtration of leukocytes (Ta- 
ble 1). Very little is known about the role of 
sieving in cell filtration processes, although the 
literature in the field of biorheology and microvas- 
cular research provides some information about 
possible effects of porous matrices on blood cell 
separation. 
Pore size effects. The degree of deformability 
of leukocytes i approximately one thousand times 
less than red blood cells. This factor is determined 
by the resistance of a blood cell to flow through a 
small capillary, 31'97 and depends on the viscoelas- 
tic properties of the cytoplasm, the plasma mem- 
brane, the cell shape, and the cell surface area/ 
volume relationship. 32 The extent of cell 
deformability is generally reduced 98 in the pres- 
ence of Ca 2 +, and therefore dependent on the an- 
ticoagulant used. 99 
As a result of differences in deformability, leu- 
kocytes have difficulty passing pores with a diam- 
eter less than 5 lxm, whereas red blood cells wilt 
easily pass 3-txm pores 29'1~176176 (Fig 3). Thus, 
when blood cell mixtures are filtered through a 
filter with pores of 3 to 8 txm, the leukocytes will 
selectively obstruct small pores by a process 
known as pore plugging. The time-dependent i -
crease in pressure, which is required to continue 
the flow of red blood cells through the filter, has 
been mathematically described by a complex func- 
tion of several factors, such as cell deformability, 
pore size, pore size distribution, pore length, blood 
cell composition, and stirring. 1~176 Simplified 
expressions are available for filtration through Nu- 
clepore filters which have well-defined capillary 
pores, 3]'97 but the relevance of these mathematical 
calculations with respect o leukocyte filters in 
which the porous tructure is very irregular is prob- 
ably low. 
It should be noted that in addition to the pore 
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at room temperature. Experimental data adapted from 
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size of the filter, the hydrostatic pressure applied 
also determines whether cells will flow through 
pores. Hemolysis may occur when the stress on the 
red blood cell membrane reaches a critical value, 
which is defined by both the filter pore size and the 
applied pressure 1~176 (Fig 3). In some cases, ie, 
when the pores are very small and the pressure is 
low, the flow of red blood cells through the filters 
can be completely stopped. 1~176 
The effects of pore size in leukocyte filters have 
been Studied by Bruil et al 1~ Using well- 
defined model filters composed of membranes, 
they found that leukocytes were only successfully 
removed when the filter pore size approached the 
size of leukocytes ( -10  Ixm). However, because 
of clogging, blood flow through such filters rap- 
idly decreased, resulting in low filter capacity. 
With asymmetric membrane filters, in which the 
pore size decreased from about 65 to 15 Ixm in the 
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direction of blood flow, both moderate removal of 
leukocytes and maintenance of flow were ob- 
tained. The clogging phenomena were also en- 
countered by Callaerts et al, who reported similar 
observations with nonwoven fiber filters in which 
the average pore size ranged from 7.3 to 14.2 
Dxm. 1o6 
Pore-branching effects. Because of relatively 
small deformation during flow, the axial velocity 
of leukocytes in capillaries is generally lower than 
that of red blood cells. 107 For example, in a cap- 
illary with a diameter of 6.8 txm the ratio of leu- 
kocyte to red blood cell velocity is 0.88 + 0.06. 34 
This difference causes a nonhomogeneous di tri- 
bution of cells and plasma in the capillary, because 
slowly moving leukocytes will retard the move- 
ment of red blood cells. 107,1o8 At branching points 
it is likely that leukocytes will continue to move in 
those capillaries with the largest diameter, but with 
time the flow rate will decrease, with the red blood 
cells continuing to flow in the other capillaries. 
The results of theoretical simulations have con- 
firmed that blood cells can be nonuniformly dis- 
tributed over two divergent capillary branches.l~ 
This deviation from a uniform distribution of cells 
increases as the diameter of the capillaries be- 
comes smaller, lO9 The effects of capillary branch- 
ing on blood cell separation become significant 
when capillaries have a diameter of approximately 
10 I, zm 32 (Fig 4). 
Margination effects. When blood flows 
through small capillaries, the red blood cells will 
generally assume the axis of the capillary. 33,110,111 
This effect is caused by the flexible and biconcave 
shape of red blood cells or by the formation of red 
blood cell aggregates, making these cells very sus- 
ceptible to radial migration in a flowing fluid. Be- 
cause the flow rate is highest in the center of ves- 
sels, red blood cells are driven to flow in the axis 
of the capillary. As a result, leukocytes, which are 
stiff and round and therefore less susceptible to 
flow, will be pushed to the capillary wal l .  111-113 
This process, known as margination, may stimu- 
late leukocytes to adhere to the capillary wall. 
Although the effects of margination on cell ad- 
hesion increase as the diameter of the capillary 
becomes maller, u3 the adhesion of leukocytes in 
small blood vessels is generally inhibited by high 
fluid shear stresses at the capillary wall, which 
become predominant in small capillaries. ~3 In this 
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Fig 4. Effect of parent capillary branching on the distribu- 
tion of red cells (RBC) into daughter branches, either for cap- 
illaries with a diameter of 10 i~m (A) and arterioles or venules 
with a diameter of 20 to 90 Ixm (B). Experimental data from 
Chien. 32 
respect it should be kept in mind that products 
released by vascular cells may affect he behavior 
of blood cells, whereas synthetic materials lack 
this property. The mechanical trapping of leuko- 
cytes by interception (Fig 2) is probably promoted 
by their margination i  blood filters. 
Cell Adhesion 
Adhesion of blood cells to solid surfaces is a 
complicated process, and the underlying mecha- 
nisms are poorly understood. The cell membrane 
should be regarded as a heterogeneous surface, 
composed of a pbospholipid matrix that contain 
clusters of glycoproteins.114 These glycoproteins, 
which are often receptors, regulate cell behavior, 
including the adhesion of the cell to a given sub- 
strate. ] 15-117 Specific leukocyte adhesion receptors 
such as LFA-1, Mac-1 and p150,95, l]s-12~ which 
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are related to a larger family of Arg-Gly-Asp 
(RGD) receptors, lz~ are often located on the 
cell membrane. Although several investigators 
have explored receptor-mediated cell adhesion 
during cell affinity chromatography, 115, ia7.123,124 
the relevance of these studies to leukocyte filtra- 
tion is not clear. 
The nonspecific adhesion of leukocytes to sur- 
faces has been extensively described in the litera- 
ture. A survey of the best-recognized factors 
known to be important follows. 
Surface chemistry. Several investigators have 
tried to relate the extent of cell adhesion to the 
chemical composition of the substrate surface, but 
very few specific studies using leukocytes are 
available. Curtis et al have studied the adhesion of 
leukocytes and baby hamster kidney (BHK) cells 
to modified polystyrene surfaces. They found that 
adhesion of both cell types was promoted by hy- 
droxyl groups, and inhibited slightly by carboxylic 
acid groups. 125-127 Bruil et al reported that the ad- 
hesion of granulocytes and lymphocytes to poly- 
urethane surfaces increased substantially after 
modification with amine groups but only slightly 
after modification with carboxylic acid groups. 128,129 
Other investigators have studied distinct cell 
types with respect o adhesion. When reviewing 
such data, it should be kept in mind that the adhe- 
sion of different cells may differ greatly. Thus, 
surfaces bearing hydroxyl groups, 125-127,130,131 
carbonyl groups, 132 and amine groups 133'134 have 
been reported to enhance cell adhesion, whereas 
sulphonate groups 125'134-136 are known to inhibit 
adhesion. The effect of carboxylic acid groups is 
controversial. Ramsey et al reported increased ad- 
hesiveness of monkey kidney cells to polystyrene 
plates after the introduction of carboxylic acid 
groups by oxygen gas plasma treatment. 137 Similar 
results were found by Klemperer and Knox, who 
reported rapid attachment of BHK cells and rat 
liver cells on chromic acid-treated polystyrene 
dishes, which was attributed to the introduction of 
carhoxylic acid groups. 135 On the other hand, 
other investigators found that the adhesion of BHK 
cells on carboxylized polystyrene surfaces was in- 
hibited only slightly as compared with carboxyl- 
ized polystyrene surfaces on which these cells 
were blocked by acetylation 125 or methylation. 127 
It should be emphasized that the introduction of 
specific chemical groups at the substrate surface 
not only changes the surface chemistry but may 
also alter the physical surface properties uch as 
charge, wettability, and microstructure. Moreover, 
the physico-chemical properties of the surface may 
readily be altered by the adsorption of proteins 
from the cell suspension medium. As each of these 
factors has inherent effects on cell adhesion, as 
will be discussed subsequently, it is difficult to 
study the effect of a single parameter.a38 This may 
explain why the results of adhesion studies re- 
ported by different investigators do not always 
agree. 
The effect of various urface chemical groups on 
cell adhesion in leukocyte filters have been studied 
by Bruil et al. 139 With the use of a surface modi- 
fication technique, they were able to prepare 
model filters that were structurally identical but 
which differed with respect to the presence of sur- 
face amine groups. When filtration was performed 
using purified leukocytes in the absence of red 
blood cells, platelets, and blood plasma, the num- 
ber of cells removed by amine group-modified fil- 
ters was significantly greater than unmodified fil- 
ters. However, no significant differences between 
the filters were found when the filtration was per- 
formed using whole blood. It was postulated that 
the physico-chemical properties of the filter sur- 
face were overshadowed by other characteristics 
affecting leukocyte behavior during filtration. 
Surface charge. Like most mammalian cells, 
leukocytes have a net negative surface charge 14~ 
caused by the presence of anionic groups such as 
phosphate, sialic acid, and carboxylic acid groups 
on the cell membrane. 142'143 Electrostatic forces, 
either repulsion or attraction, may consequently 
influence cell adhesion. 141,144 It has been reported 
that whereas negatively charged substrates reduce 
cell adhesion,t34'145'146 positively charged sub- 
strates promote it. 134'145-148 These findings are in 
general agreement with the previously discussed 
effects of ionizable functional groups, which may 
easily affect he charge of solid surfaces. 
The Derjaguin, Landau, Verwey, and Overbeek 
theory, which describes the free energy of a col- 
loidal particle as a function of the inter-particle 
distance, has often been used to predict he rate of 
cell adhesion to surfaces with different surface 
charges. 145'149'150 This theory defines the deposi- 
tion rate of cells to a solid surface by the presence 
and height of an energy barrier, which depends on 
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electrostatic interactions and London-van der 
Waals interactions between the surface and the 
cells. It follows from this theory that the chance for 
cells to adhere is smaller when a surface is more 
negatively charged. 
However, leukocyte adhesion is not necessarily 
inhibited by negatively charged surfaces. Leuko- 
cytes often form pseudopods,151 which easily pen- 
etrate the electrical double layer of the negative 
substrate, thus facilitating close contact and the 
molecular interactions between the cells and the 
surface. 141 Groth et al have reported that the num- 
ber of leukocytes adhering to polyurethane sur- 
faces increases when the surface becomes more 
negative. 152 
Surface wettability. There exists a widely ac- 
cepted concept hat wettable, or hydrophilic, sur- 
faces promote the adhesion of leukocytes as com- 
pared with nonwettable,  or hydrophobic ,  
surfaces. 4~ However, contradictory re- 
suits were reported by Lim and Cooper, who used 
a series of polyurethane surfaces differing in wet- 
tability and found that most granulocytes adhered 
to the most hydrophobic surface. 154 Van Kampen 
et al found large numbers of adherent leukocytes in 
dogs on implants consisting of both hydrophobic 
and hydrophilic polyaminoacids.155 Some investi- 
gators have used the hydrophobic interactions of 
blood cells with hydrophobic substrates toseparate 
blood cells by affinity chromatography. 156'157 
To explain the increase of leukocyte adhesion to 
surfaces with increased wettability, Neumann et al 
used a thermodynamic model in which the change 
in free energy resulting from adhesion was related 
to the surface free energy of the solid sur- 
face, 158'159 which in turn is related to the surface 
wettability.160 This model has also been used to 
relate the adhesion of platelets 158' 161 and red blood 
cells 159'162 to the wettability of the solid surface 
and to determine if the efficiency of microaggre- 
gate filters depends on the wettability of the filter 
material. 163 In the latter study it was shown that 
the number of leukocytes and platelets retained by 
these filters was proportional to the surface free 
energy of the filter material. The same theory 
could probably be used to explain the different 
efficiencies of the different leukocyte filters. How- 
ever, it should be emphasized that the model does 
not account for effects of surface charge on cell 
adhesion. 
Surface microstructure. Synthetic substrates 
are generally nonhomogeneous and sometimes 
show a microstructure, ie, the surface consists of 
small microdomains differing in chemical compo- 
sition. Because the membrane structure of most 
cells may easily rearrange during adhesion, 114 it is 
likely that cell adhesion is influenced by the mi- 
crostructure of the substrate surface, ie, a structure 
consisting of small microdomains differing in 
chemical composition. Kataoka et al have studied 
the adhesion of blood cells onto materials with 
various microphase-separated structures, com- 
posed of neutral-charged, 164,165 hydrophobic- 
hydrophilic, 166'167 or crystalline-amorphous 168'169 
domains. The degree of cell adhesion to these ma- 
terials, which is influenced by the size and type of 
the microdomain at the solid surface, was in gen- 
eral low compared with surfaces without such a 
microstructure. Moreover, it has been reported by 
Okano et al that different plasma proteins selec- 
tively adsorb to either hydrophilic or hydrophobic 
microdomains, 17~ thereby forming protein-coated 
microstructures, with similar effects on cell adhe- 
sion as described previously for uncoated micro- 
structures. 
Several frequently used block copolymers uch 
as polyurethanes 171'172 are known to have a mi- 
crophase-separated surface structure. Cell adhe- 
sion to such materials may be substantially reduced 
compared with materials with a homogeneous sur- 
face structure. 
Surface morphology. Certain surface morpho- 
logical features uch as porosity, curvature, and 
texture are known to influence cell adhesion to 
extracellular substrates. 4~ Furthermore, the adhe- 
sion of platelets 173 and red blood cells 174 to porous 
surfaces is often diminished during perfusion of 
the suspending fluid through the pores of the sur- 
face. However, fibroblasts adhere more firmly to 
porous surfaces compared with smooth sur- 
faces. 175 Surface roughness is also known to in- 
fluence cell adhesion, as was shown by the pattern 
of erythrocyte adhesion to a number of sub- 
strates.176 Macrophages and platelets adhere pref- 
erentially to rough surfaces compared with smooth 
surfaces under conditions of flow. 177'178 Guidoin 
et al observed larger numbers of adherent leuko- 
cytes and platelet aggregates in blood filters with 
an irregular and imperfect surface texture com- 
pared with filters having a smooth surface. 65 
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The effect of surface roughness on cell adhesion 
was attributed to the presence of air nuclei at rough 
surfaces, which may enhance cell adhesion. 179 Air 
nuclei at rough surfaces, formed particularly in hy- 
drophobic substrates, are known to activate the 
complement system, 180 which in turn may mediate 
the adhesion of leukocytes to artificial surfaces. 
Complement activation. The human comple- 
ment system is a complex group of at least 25 
plasma proteins that, after activation, interact with 
each other in a sequential manner to produce bio- 
logical effector molecules. 181,182 One of the phys- 
iological functions of the complement system is 
the regulation of the immunological response to 
bacterial or viral infections via the so-called clas- 
sical pathway. Complement activation is also 
known to be involved in the adhesion of leukocytes 
to artificial surfaces. 183-185 Activation of the 
Ca 2+- and Mg2+-dependent al ernative pathway 
generates C3a and C5a fragments, which are 
known to mediate the adhesion and aggregation of
leukocytes. ~ 85- lSV 
The extent of complement activation depends on 
the physico-chemical properties of the artificial 
surface. ~88'189 Protein preadsorption, IgG in par- 
ticular, 19~ and the presence of air nuclei at the 
material surface ~8~ alter the effect of complement. 
The complement activation potential of some com- 
monly used polymers is shown in Table 3. Nega- 
tively charged surfaces are known to have a rela- 
tively low propensity to activate complement, 
probably because of adsorption (ie, inactivation) of 
the cationic C5a. 191 Nucleophilic groups such as 
amine 19~ and hydroxyl 186'193 have been re- 
ported to activate the complement system. In this 
respect, it should be noted that functional groups 
of denaturated plasma proteins preadsorbed onto 
the material surface rather than the material itself 
may cause complement activation. 188,189 
Protein adsorption. One of the first events to 
occur when materials are exposed to blood, even 
before cells can adhere, is the adsorption of plasma 
proteins to the surface. During this process, there 
is competition between the various proteins present 
in the plasma. The initially adsorbed small pro- 
teins, which have a high diffusion coefficient and 
occur in a high concentration, are sequentially dis- 
placed by larger proteins, which have a higher af- 
finity toward the surface but are present in a lower 
concentration and have a lower diffusion coeffi- 
cient. Gradual displacement of adsorbed proteins, 
known as the Vroman effect, occurs on hydro- 
philic surfaces in the following sequence; albumin, 
IgG, fibrinogen, fibronectin, high molecular 
Table 3. Survey of Polymer Material 9  for Complement Activation and Leukocyte Adhesion Potential 
Complement Leukocyte 
Materia(s)/Common Name Activation* Adhesiont References 
Polyacrylonitrile 9 ee 9 194-196 
Polycarbonate 9 9 194, 195, 197 
Polyethylene 9 ee 158, 159, 188, 198-200 
Polypropylene 9 ee 189, 195, 201 
Polytetrafluoroethylene/Teflon 9 9 158, 159, 180, 195, 202 
Polystyrene 9 9 126, 158, 159, 189, 195, 203 
Polysulfone 9 9 194, 195, 201 
Polyvinylchloride 9 9 189, 195, 200 
Cellulose acetate ee eee 60, 194, 195, 198 
Polydimethylsiloxane/Silicon rubber ee ee 158, 180, 188, 199, 201 
Poly(ethylene terephthalate)/Dacron ee eee 60, 158, 195, 202 
Poly(methyl methacrylate) ee eee 185, 189, 194, 195, 198 
Polyurethanes ee ee 129, 153, 188, 189, 195, 204 
Cellulose/Cellophane eee eee 180, 194, 195, 201,204 
Polyaramids/Nylons eee eee 158, 185, 195 
Poly(hydroxyethylene methacrylate) eee 9 186, 203 
Polyvinylalcohol eee 9 198, 204, 206 
* Relative potential to activate complement (more dots, more activation), arbitrarily classified according to hemolytic activity or 
C3a/C6a generation. Results taken from various studies by different investigators. 
t Relative susceptibility to leukocyte adhesion (more dots, more adhesion), arbitrarily classified after comparison of results from 
various studies by different investigators. 
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weight kininogen, and factor XlI. 206-209 The rate 
and amount of protein adsorption are dependent on 
the physico-chemical properties of the material 
surface. 2~176 In general, proteins adsorb stronger 
and to a larger extent o hydrophobic surfaces than 
to hydrophilic surfaces. 211-213 
Leukocyte adhesion to surfaces is largely influ- 
enced by preadsorbed proteins. It is well known 
that albumin has an inhibitory effect on the adhe- 
sion of leukocytes to solid surfaces, 40'126'158'214'215 
whereas globulins enhance the adhesion of leuko- 
cytes. 2~ Fibronectin (Fn) 216'217 acts as a 
bridging molecule between the cells and the sub- 
strate in many cell-adhesion processes. 218'219 Al- 
though the concentration f Fn in plasma is low, it 
has been reported that Fn is a normal constituent of
the leukocyte membrane, which may be secreted 
on activation of the celts. 22~ Several investigators 
have used the cell adhesive properties of fibronec- 
tin, 221 and the RGD peptide sequence, 122'2~ 
which is regarded as the active site of fibronec- 
tin, 222'223 to enhance cell adhesion to artificial sur- 
faces. 
The plasma concentration level required to 
achieve optimal protein adsorption for optimal leu- 
kocyte adhesion during filtration is not known. 
The results of experiments with leukocytes re- 
ported by Bruil et al favor the use of filtration 
conditions in which the concentration f plasma is 
reduced, zz4 However, Shimizu et al found that the 
leukocyte depletion efficiency of polyester fiber 
filters did not alter when the cells were stored is a 
plasma-poor medium. 225 
Platelet adhesion. There is evidence that ad- 
herent platelets promote subsequent adhesion of 
leukocytes. It was reported in 1961 by Garvin that 
the extent of adhesion of polymorphonuclear leu- 
kocytes to siliconized glass wool was dependent on 
prior adherence of platelets. 37 Similar effects were 
reported by other investigators. 226'z27 Bruil et al 
have studied the adhesion of granulocytes tomod- 
ified polyurethane surfaces under flow conditions 
and found that the presence of platelets in the cell 
suspension medium led to a significant increase in 
the number of adherent cells. 224 Steneker et al 
showed that the break-through point during filtra- 
tion of leukocytes was achieved earlier in the ab- 
sence of platelets in the cell suspension than in the 
presence of platelets. 228 It has also been reported 
that activated platelets can release adhesive pro- 
teins such as fibrinogen, fibronectin, and von 
Willebrand factor, which may promote leukocyte 
adhesion. 227 Alternatively, activated platelets may 
express a receptor generally known as PADGEM 
(platelet activation-dependent granule-external 
membrane protein; GMP-140), to which leuko- 
cytes may adhere. 229-231 
The physiological aspects of platelet-leukocyte 
interactions have been well documented, ~32 but the 
significance of these interactions with respect o 
leukocyte filtrations has received less attention. 
Swank studied the attachment of cell aggregates to
glass wool filters by a microscopic technique and 
concluded that adhesion of platelets to leukocytes 
is essential for effective filtration. 16 Steneker et al 
have recently performed an electron microscopic 
examination of leukocyte depletion in leukocyte 
filters in which the adhesion of granulocytes to 
platelets was observed. 233 Similar observations 
were also reported by Bruil et al. 104 It thus seems 
that the adhesion of granulocytes toplatelets is an 
important factor for the depletion of leukocytes by 
leukodepletion filters. 
Composition of blood. The composition of the 
blood may influence leukocyte adhesion in many 
aspects. Because ach of the leukocyte subpopu- 
lations has a different tendency to adhere to artifi- 
cial surfaces (Table 1), the overall degree of leu- 
kocyte adhesion depends on the concentration a d 
composition of the leukocyte population. The 
number of platelets i  important with respect to the 
effects already discussed. Red blood cells may in- 
fluence leukocyte adhesion under conditions of 
flow, because these cells are known to promote the 
migration of leukocytes to the substrate surface. 
Several investigators have reported that leuko- 
cyte adhesion is reduced in the presence of 
plasma. 40'201'215'224 Forrester et al found that leu- 
kocyte adhesion to glass slides was inhibited when 
the cells were suspended in autologous plasma 215 
probably because of the adsorption of albumin to 
the substrate. Bruil et al found that the number of 
granulocytes that adhered to modified polyure- 
thane films from saline was approximately four 
times high compared with the number that adhered 
from plasma in saline. 224 However, some investi- 
gators have reported that plasma does not inhibit 
but sometimes even promotes leukocyte adhesion 
to glass surfaces. 38'234 
Divalent ions, Ca 2 + and Mg ~ + in particular, are 
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generally known to promote leukocyte adhe- 
sion. 37'4~ Hoover et a1235 re- 
ported that the extent of leukocyte adhesion to en- 
dothelium is maximal in the presence of Mn 2+, 
followed by Zn 2+ > Ni 2+ > Mg 2+ > Ba 2+ > 
Ca 2+. With respect to leukocyte filtration, it 
should be noted that not only the adhesiveness but 
also the deformability of leukocytes i  affected by 
divalent ions. 98'99 
The effect of anticoagulants on leukocyte adhe- 
sion is primarily caused by the lowering of the 
concentration of divalent ions, 37 except for hepa- 
rin, which does not bind Ca 2+ and Mg 2+ . In ci- 
trate-anticoagulated blood the concentration of 
Ca 2 + and Mg 2+ , although low, is still enough to 
permit leukocyte adhesion. 37 When ethylene- 
diaminetetraacetic acid (EDTA) or oxalate is used 
as anticoagulant, he concentration of free Ca 2+ 
and Mg 2+ is negligible and leukocyte adhesion is 
inhibited.37, 39,236 
Mathematical Models 
Mathematical models to describe the leukocyte 
filtration process, based on current knowledge of 
filtration mechanisms, may be helpful to explain 
results obtained with leukocyte filtration and to 
optimize filters and filtration procedures. Only a 
few attempts to describe mathematically the leu- 
kocyte filtration process are known. Diepenhorst 
evaluated a mathematical model, originally de- 
rived to explain the removal of ferrous hydroxide 
particles from ground water through sand beds, to 
describe the filtration of leukocytes through cotton 
wool filters but did not succeed in explaining his 
experimental results. 237 More recently, Prins de- 
veloped a computer model to explain the depletion 
of leukocytes in filters composed of filter segments 
with different leukocyte-trapping efficiencies. 238 
However, a shortcoming of the model was that its 
parameters were based on empirically derived 
probability factors, and therefore the theoretical 
value of the model is minimal. Moreover, the sta- 
tistical basis of the model reduces its adaptivity in 
process engineering and product design. 
More sophisticated filtration models have been 
derived to optimize applications in the field of 
chemical engineering. 239-z42 Bruil et a1243 have 
adapted the basic theory from these studies to de- 
scribe the leukocyte filtration process. With the 
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use of this theory it was possible to compare quan- 
titatively the filtration characteristics of different 
filter materials and to calcuiate the dimensions of a 
leukocyte filter composed of a specific material. 
The model is based on the general hypothesis of 
depth filtration, which states that the particle con- 
centration decreases per unit of filter length (Sc/Oh) 
and is proportional to the concentration of the par- 
ticles in suspension (C)83'239'244: 
c]c 
Oh Xc (1) 
The filtration coefficient h is a measure of the ef- 
ficiency of the filter and was first introduced by 
Iwasaki 245 in 1937. The filtration coefficient may 
be regarded as the particle capture probability, ie, 
the fraction of particles that is captured per unit of 
filter length. During filtration, h changes as a func- 
tion of time, because the amount of material al- 
ready deposited in the filter, or, influences the fil- 
tration of the other particles present. It is assumed 
that a limited number of retention sites (O'max) in 
the filter is accessible for the capture of particles. 
Therefore, the filter efficiency decreases on occu- 
pation of these retention sites during filtration. 
Hence, a linear decrease of h with ~r is often as- 
sumed 9~ 
(~ X = ho 1 - (2) 
O'ma x
In equation (2) h o is the filtration coefficient of the 
noncontaminated filter. As the value of h o depends 
purely on the properties of the filter material, h o 
can be described as function of the filter proper- 
ties. Some investigators have postulated that h o is 
proportional to the specific surface area (S) of the 
filter when adhesion is the predominant mecha- 
nism for particle depletion. 244'246 Assuming that S 
is inversely proportional to the filter pore size d, 104 
it follows that: 
1 
Xo - -; (3) a 
The h o values of model leukocyte filters, com- 
posed of membranes with variable average poor 
sizes, were found to agree reasonably well with 
this relation. ~43 
During leukocyte filtration the filter efficiency 
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may increase on clogging of the filter. Deposited 
platelets may enhance the retention of leukocytes 
from the blood cell suspension. 224'226-228 More- 
over, material deposited in the filter may reduce 
the apparent pore size in the filter, thus improving 
the filter efficiency. 104-106 Some investigators have 
proposed a liner expression for h as a function of 
~r, in which a factor ~ accounts for the positive 
effect of particle deposition in the filter on filter 
efficiency87,245: 
k = ko 1 + ~ (4) 
Several other elations between h and ~r have been 
reported in the literature. 84,86,244 It was postulated 
by Bruil et al that the filtration coefficient in leu- 
kocyte filters can be expressed as a linear combi- 
nation of Equations (2) and (4)243: 
h=ko 1 - 1 +~ (5) O'ma x 
This expression i cludes both the effects of filter 
properties (first term; ko), filter saturation (second 
term) and cell-cell interaction in the filter (third 
term). In this respect, the constant factor ~ can be 
defined as a cell-cell interaction parameter, which 
accounts for the positive effects of deposited cells 
on the retention of other cells. 
The amount of material deposited in the filter as 
a function of time (t) can be calculated from the 
mass balance for particles in a filter element with 
thickness Oh, which can be approximated by86: 
&r Oc 
--Ot + w ~ = 0 (6) 
Here, the fluid flow rate through the filter, w, is 
expressed in unit distance per unit time. The vol- 
ume flow rate can eventually be calculated by mul- 
tiplication of w with the planar filter surface area 
A, Hence, the leukocyte filtration process can be 
mathematically described by a differential system 
of the three Equations (1), (5) and (6), However, 
this is not an easy task. Only few cases of the 
differential system can be solved analytically. 
When ~ = 0, ie, when cell-cell interaction is 
not considered to be important in leukocyte filtra- 
tion, equation (5) simplifies to equation (2), and an 
analytical expression for the time-dependent 
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purity of the filtered product (C/Co) can be ob- 
tained86,94,243: 
c 1 
C o 1 + (exp(koh) - 1)exp(- hoWCot/(Ymax) 
(7) 
Another simplification can be made when ~ = 1. 
In this case, the analytical solution of the differ- 
ential equation becomesSr'243: 
C 
Co 
1 + exp(2koWCot/Crmax)~ 
exp(2koWCotRrma~) - 1/ 
~/l "4- \ \ex -~(~ ~ T / ( (  l -]  exp(2)koWCo//O'max)~2_ l  exp(2}koh ) 
(8) 
In the general case, in which the value of ~ is 
variable, the differential system cannot be solved 
analytically. However, a numerical solution has 
been obtained and applied to explain the effects of 
cell-cell interaction in leukocyte filtration. 243 If 
followed from this theory that the filtration break- 
through point, ie, the filtered volume after which 
an increase of the leukocyte content in the filtrate 
can be measured, is shifted toward higher volumes 
when the value of ~ is increased. 
Filtration characteristics. To describe the re- 
sults of filtration experiments by means of the gen- 
eral mathematical formulation for the filtration 
process, 243 at least three filtration parameters, ~, 
cr . . . .  and ho, should be solved independently. Be- 
cause theoretical relations for these parameters 
with the properties of the filter are not yet well 
developed, this can only be achieved by trial and 
error. However, the problem is simplified when 
the effects of cell-cell interaction in the filter are 
negligible compared with the leukocyte retention 
by the filter material itself. In this case, when ~ 
0, the filtration process is described by Equation 
(7), and the parameters O'ma x and ho can be deter- 
mined from the results of filtration experiments 
according to a method described by Heertjes and 
Zuideveld. 94 Leukocyte filtration data reported for 
different types of leukocyte filters 59'71 fit well with 
this theory (Fig 5). When the filtration parameters 
c o, h, A, and w are accurately known, the values of 
O'ma x and k o can be determined precisely and a 
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quantitative comparison of the filtration character- 
istics of different filter types is possible. 
Filter design. Another application of the 
model is to calculate the optimal dimensions of a 
leukocyte filter composed of a specific uniform 
material. For exp (hoh*) >> 1, the nominal filter 
thickness h* required to prepare a leukocyte-poor 
suspension with volume V* and a permissible l u- 
kocyte concentration c*, can be derived from 
Equation (7), 243 resulting in: 
1(co) co , 
h*=~oln  ~ +A--~m~ (9) 
Thus, when the filter parameters ho and (rma xas 
well as the leukocyte concentration c o in the sus- 
pension applied to the filter are known, the dimen- 
sions of the filter, A and h, can be optimized by 
using Equation (9). The values of ho and ~max can 
be determined by curve fitting to obtain the filtra- 
tion characteristics of different filters (Fig 5). 
CONCLUSIONS 
The evolution of leukocyte filters to prepare leu- 
kocyte-depleted red blood cell products has been 
reviewed. Currently available leukocyte filters re- 
move more than 99% of the leukocytes from whole 
blood, whereas red blood cell loss is only small. 
Although current filter performances are accept- 
able, optimization is still desirable. However, fur- 
ther improvement of leukocyte filters has been 
hampered by a lack of knowledge about he mech- 
anisms causing the depletion of leukocytes by the 
filters. 
According to the literature, many factors, many 
of which are interrelated, may be involved in the 
function of the leukocyte filters. Although most of 
these factors have been intensively studied, very 
little is known about heir relevance in the leuko- 
cyte filtration processes. Considering the complex- 
ity of the structure of current leukocyte filters and 
the composition of the blood to be filtered, it 
seems that the leukocyte filtration process can be 
defined by a complex interaction of the above 
mentioned factors, instead of by one single factor, 
as was originally suggested by several investiga- 
tors. 19'21'25'64'81'106 Although many details about 
the leukocyte filtration mechanisms are still to be 
elucidated, the filtration process can be described 
by a mathematical model. The use of this model 
may be helpful to design novel leukocyte filters. 
Recognition of the complexity of leukocyte fil- 
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Fig 5. Theoretical fit of a leukocyte filtration curve ob- 
tained by filtration of a blood cell suspension through an ex- 
perimental cotton wood filter (A), and Imugard 1(3500 filter 
(B), and an Erypur filter (C). Experimental data from Diepen- 
horst at el. 7~ (A) and Reesink et al. s9 (B and C). Fixed param- 
eters were set at ~ = 0, h = 25 cm, A = 25 cm 2, w = 0.03 om 
x s -1, and r = 5 x 106 leukocytes x cm -3 (A) or 2.1 x 10 e 
leukocytes x cm -3 (B and C). 
tration mechanisms is important in many respects. 
First, knowledge of the mechanisms causing the 
depletion of leukocytes by leukocyte filters is es- 
sential for further development and optimization of
filter materials. Second, understanding the rela- 
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t ions between fi lter eff ic iency and b lood cell func- 
t ional ity supports the standardizat ion of protocols 
for b lood col lect ion, b lood storage, and compo-  
nent  preparat ion.  Third,  awareness of  the critical 
steps dur ing the leukocyte f i l tration process may 
st imulate b lood bankers to respect and obey the 
direct ions for leukocyte f i l trat ion procedures g iven 
by fi lter manufacturers.  This may eventual ly  lead 
to a safer and more eff ic ient preparat ion of  leuko- 
cyte-depleted blood products.  
REFERENCES 
1. Sirchia G, Parravicini A, Rebulla P, et al: Effectiveness 
of red blood ceils filtered through cotton wool to prevent an- 
tileukocyte antibody production in multitransfused patients. 
Vox Sang 42:190-197, 1982 
2. Snyder EL: Clinical use of white-cell poor blood compo- 
nents. Transfusion 29:568-571, 1989 
3. Vakkila J, Myllyl~i G: Amount and type of leukocytes in 
'leukocyte-free' r d cell and platelet concentrates. Vox Sang 
53:76-82, 1987 
4. Eernisse JG, Brand A: Prevention of platelet refractori- 
ness due to HLA antibodies by administration f leukocyte- 
poor blood components. Exp Hematol 9:77-83, 1981 
5. Saarinnen UM, Kekomaki R, Slimes MA, et al: Effective 
prophylaxis against platelet refractoriness in multitransfused 
patients by use of leukocyte-free blood components. Blood 
75:512-517, 1990 
6. Slichter S: Platelet alloimmunization, i  Anderson KC, 
Ness PM (eds): Scientific Basis of Transfusion Medicine. Phil- 
adelphia, PA, Saunders, 1994, pp 527-543 
7. Perkins HA: Is white cell reduction cost-effective. Trans- 
fusion 33:626-628, 1993 
8. Friedman LI, Stromberg RR, Wagner S J: Reducing the 
ineffectivity of blood components: what we have learned, in 
Nance ST (ed): Blood Supply: Perceptions and Prospects for the 
Future. Arlington, VA, American Association of Blood Banks, 
1994, pp 139-167 
9. Eisenfield L, Silver H, McLaughlin J, et al: Prevention of 
transfusion-associated cytomegalovirus infection in neonatal 
patients by the removal of white cells from blood. Transfusion 
32:205-209, 1992 
10. AI EJM, Visser SCE, Broersen SM, et al: Reduction of 
HTLVl-infected cells in blood by leukocyte filtration. Ann 
Hematol 67:295-300, 1993 
11. de Graan-Hentzen YCE, Gratema JW, Mudde GC, et al: 
Prevention of primary cytomegalovirus infection in patients 
with hematologic malignancies by intensive white cell deple- 
tion of blood products. Transfusion 29:757-760, 1989 
12. Bowden RA, Slichter SJ, Sayers MH, et al: Use of leu- 
kocyte-depleted platelets and cytomegalovirus seronegative r d 
blood cells for prevention ofprimary cytomegalovirus infection 
after marrow transplant. Blood 78:246-250, 1991 
13. Perkins HA: Transfusion-induced immunologic unre- 
sponsiveness. Transfus Med Rev 2:196-203, 1988 
14. Anderson KC, Goodnough LT, Sayers M, et al: Varia- 
tion in blood component irradiation practice: Implications for 
prevention of transfuse-associated graft-versus-host disease. 
Blood 77:2096-2102, 1991 
15. Brand A: Leukocyte-poor blood: Arguments and guide- 
lines. Vox Sang 67:129-131, 1994 (suppl 3) 
16. Swank RL: Alteration of b|ood on storage: Measurement 
of adhesiveness of 'aging' platelets and leukocytes and their 
removal by filtration. N Engl J Med 265:728-733, 1961 
17. Heddle NM, Klama LN, Griffith L, et al: A prospective 
study to identify the risk factors associated with acute reactions 
to platelet and red cell transfusions. Transfusion 33:794-797, 
1993 
18. Snyder EL, Bookbinder M: Role of microaggregate 
blood filtration in clinical medicine. Transfusion 23:460-470, 
1983 
19. Wenz B: Clinical and laboratory precautions that reduce 
the adverse reactions, alloimmunization, i fectivity, and pos- 
sibly immunomodulation associated with homologous transfu- 
sions. Transfus Med Rev 4:3-7, 1990 (suppl 1) 
20. Prins HK, de Bruijn JCGH, Hinrichs HPJ, et al: Pre- 
vention of microaggregate formation by removal of 'buffy- 
coats.' Vox Sang 39:48-51, 1980 
21. Wenz B: Leukocyte-poor blood. CRC Crit Rev ClinLab 
Sci 24:1-20, 1986 
22. Treleaven JG, McGregor M, Blagdon J: An evaluation 
of some methods currently available on the production of leu- 
cocyte-poor blood. Clin Lab Haematol 6:45-49, 1984 
23. Meryman HT: The preparation of red ceils depleted of 
leukocytes--Review and evaluation. Transfusion 26:101-106, 
1986 
24. James J, Matthews RN, Holdsworth RF, et al: The role 
of filtration in the provision of leukocyte-poor red cells to mul- 
titransfnsed patients. Pathology 18:127-130, 1986 
25. Wenz B: Leukocyte-free red cells: The evolution of a 
safer blood product, in McCarty LJ, Baldwin ML (eds): Con- 
troversies of Leukocyte-Poor Blood and Components. Arling- 
ton, VA, American Association of Blood Banks, 1989, pp 27- 
48 
26. Baker FJ, Silverton RE: Introduction tohaematology, in 
Introduction to Medical Laboratory Technology, London, En- 
gland, Butterworths, 1985, pp 305-311 
27. Roos D, de Boer M: Purification and cryopreservation of 
phagocytes from human blood. Methods Enzymol 132:225- 
243, 1986 
28. Schmid-Schrnbein GW: Morphometry ofhuman leuko- 
cytes. Blood 56:866-875, 1980 
29. Lichtman MA, Gregory A, Kearney E: Rheology of leu- 
kocytes, leukocyte suspensions, and blood in leukemia. J Clin 
Invest 52:350-358, 1973 
30. Lichtman MA, Keamey EA: The filterability of normal 
and leukemic human leukocytes. Blood Ceils 2:491-506, 1976 
31. Chien S, Schmalzer EA, Lee MML, et al: Role of white 
blood cells in filtration of blood cells suspensions. Biorheology 
20:11-27, 1983 
32. Chien S: Role of blood in microcirculatory regulation. 
Microvasc Res 29:129-151, 1985 
33. Cokelet GR: The rheology and tube flow of blood, in 
LEUKOCYTE REMOVAL BY FILTRATION 161 
Skalak R, Chien S (eds): Handbook of Bioengineering. New 
York, NY, McGraw-Hill, 1987, pp 14.1-14.17 
34. Schmid-Sch6nbein GW: Rheology of leukocytes, in 
Skalak R, Chien S (eds): Handbook of Bioengineering. New 
York, NY, McGraw-Hill, 1987, pp 13.1-13.25 
35. Franzini E, Moutard Martin F, Thao Chan M: Leukocyte 
filterability: Its measurement i  the laboratory and effects of 
pentoxifylline. Clin Hemorheol 8:477-484, 1988 
36. Br~nemark PI, Lindstrrm J: Shape of circulating cor- 
puscles. Biorheology 1:139-142, 1963 
37. Garvin JE: Factors affecting the adhesiveness of human 
leukocytes and platelets in vitro. J Exp Med 114:51-73, 1961 
38. Lamvik JO: Separation of lymphocytes from human 
blood. Acta Haemat 35:294-303, 1966 
39. MacGregor RR, Spagnuolo PJ, Lentnek AL: Inhibition 
of granulocyte adherence by ethanol, prednisone and aspirin, 
measured with an assay system. N Engl J Med 291:642-646, 
1974 
40. Grinnell F: Cellular adhesiveness and extracellular sub- 
strata. Int Rev Cytology 53:65-144, 1978 
41. Rinehart JJ, Gormus BJ, Lange P, et al: A new method 
for isolation of human monocytes. J Immunol Methods 23:207- 
212, 1978 
42. Rasp FL, Clawson CC, Hoidal JR, et ah Quantitation 
and scanning electron microscopic comparison of human alve- 
olar macrophage and polymorphonuclear leukocyte adherence 
to nylon fibers. J Reticuloendothel Soc 25:101-109, 1979 
43. Absolom DR, van Oss C J, Neumann AW: Elution of 
human granulocytes from nylon fibers by means of repulsive 
van der Waats forces. Transfusion 21:663-674, 1981 
44. Meryman HT, Boss J, Lebovitz R: The preparation of
leukocyte-poor red cells: A comparative study. Transfusion 20: 
285-292, 1980 
45. Chaplin H, Brittingham TE, Cassell M: Methods for 
preparation of suspensions of buffy-coat-poor red blood cells 
for transfusion. Am J Clin Pathol 31:373-383, 1959 
46. Sirchia G, Parravicini A, Rebulla P, et ah Evaluation of 
three procedures for the preparation of leukocyte-poor and leu- 
kocyte-free red blood cells for transfusion. Vox Sang 38:197- 
204, 1980 
47. Cassell M, Philips DR, Chaplin H: Transfusion of buffy- 
coat-poor red cell suspension prepared by dextran sedimenta- 
tion: Description of newly-designed quipment and evaluation 
of its use. Transfusion 4:216-220, 1962 
48. Wenz B, Apuzzo JH, Ahuja KK: The preparation of 
leukocyte-poor red cells from liquid stored blood: An evalua- 
tion of the Haemonetics | 102 cell washing systems. Transfu- 
sion 20:306-310, 1980 
49. Uda M, Naito S, Yamamoto K, et ah Optimal protocol 
for preparation of leukocyte-poor red cells with a blood cell 
processor. Transfusion 22:48-50, 1984 
50. Smith AU: Prevention of hemolysis during freezing and 
thawing of red cells. Lancet 2:901-903, 1950 
51. Crowley JP, Wade PH, Wish C: The purification of red 
ceils for transfusion by freeze-preservation and washing. V. 
Red cell recovery and residual leukocytes after freeze- 
preservations with high concentrations of glycerol and washing 
in various ystems. Transfusion 17:1-7, 1977 
52. Amer KA, Pepper DS, Urbaniak SJ: Lymphocyte, gran- 
ulocyte and platelet contamination f blood frozen by the low 
glycerol iquid nitrogen technique. Br J Haematol 44:253-261, 
1980 
53. Snyder EL, Root RK, Hezzey A, et ah Effect of micro- 
aggregate blood filtration of granulocyte concentrations in 
vitro. Transfusion 23:25-29, 1983 
54. Snyder EL, Root RK, McLeod B, et ah Activation of 
complement by blood transfusion filters. Vox Sang 45:288- 
293, 1983 
55. Wenz B, Gurtlinger KF, O'Toole AM, et ah Preparation 
of granulocyte-poor red blood cells by microaggregate filtra- 
tion. Vox Sang 39:282-287, 1980 
56. Mijovic V, Brozovic B, Hughes ASB, et ah Leukocyte- 
depleted blood--A comparison of filtration techniques. Trans- 
fusion 23:30-32, 1983 
57. Meryman HT: Transfusion-induced alloimmunization 
and immunosuppression a d the effects of leukocyte depletion. 
Transfus Med Rev 3:180-193, 1989 
58. Reverberi R, Menini C: Clinical efficacy of five filters 
specific for leukocyte removal. Vox Sang 58:188-191, 1990 
59. Reesink HW, Veldman H, Henrichs HJ, et al: Removal 
of leukocytes from blood by fibre filtration--A comparison 
study on the performance of two commercially available filters. 
Vox Sang 42:281-288, 1982 
60. Pietersz RNI, Steneker I, Reesink HW, et al: Compar- 
ison of five different filters for the removal of leukocytes from 
red cell concentrates. Vox Sang 62:76-81, 1992 
61. Pikul FJ: Effectiveness of two synthetic fiber filters for 
removing white cells from AS-1 red cells. Transfusion 29:590- 
595, 1989 
62. Rebulla P, Porretti L, Bertolini F, et ah White cell- 
reduced red ceils prepared by filtration: A critical evaluation of 
current filters and methods for counting residual white cells. 
Transfusion 33:128-133, 1993 
63. Steneker I, Biewenga J: Histological and immunohisto- 
chemical studies on the preparation of white cell-poor ed cell 
concentrates byfiltration: The filtration process using three dif- 
ferent polyester filters. Transfusion 31:40-60, 1991 
64. Sirchia G, Rebulla P, Parravicini A, et ah Leukocyte 
depletion of red cell units at the bedside by transfusion through 
a new filter. Transfusion 27:402-405, 1987 
65. Guidoin R, Taylor K, Bain WH: Blood filter evaluation. 
Biomat Med Dev Art Org 5:317-336, 1977 
66. Fleming A: A simple method of removing leucocytes 
from blood. Br J Exp Pathol 7:281-286, 1926 
67. Greenwalt TJ, Gajewski M, McKenna JL: A new 
method for preparing buffy coat-poor blood. Transfusion 2: 
221-229, 1962 
68. Eisen SA, Wedner HJ, Parker CW: Isolation of pure 
human periphereal b ood T-lymphocytes u ing nylon wool col- 
umns. Immunol Comm 1:571-577, 1972 
69. Klock JC, Stossel TP: Detection, pathogenesis, and pre- 
vention of damage to human granulocytes caused by interaction 
with nylon wool fiber. J Clin Invest 60:1183-1190, 1977 
70. Schiffer CA, Sanel FT, Young VB: Reversal of granu- 
locyte adherence to nylon fibers using local anestic agents: 
Possible application to filtration leukapheresis. Blood 50:213- 
225, 1977 
71. Diepenhorst P, Sprokholt R, Prins HK: Removal of leu- 
kocytes from whole blood and erythrocyte suspensions by fil- 
tration through cotton wool. Vox Sang 23:308-320, 1972 
72. Diepenhorst P, Leurink H, Scheepstra HMH, et ah Re- 
162 BRUIL ET AL 
moval of leukocytes from whole blood and erythrocyte suspen- 
sions by filtration through cotton wool, in Diepenhorst P (ed): 
Removal of Leukocytes from Blood by Filtration Through Cot- 
ton Wool. thesis, Delft University of Technology, The Neth- 
erlands, 1974, pp 78-84 
73. Kikugawa K, Minoshima K: Filter columns for prepa- 
ration of leukocyte-poor blood for transfusion. Vox Sang 34: 
281-290, 1978 
74. Olijslager J, Hennink WE, Rejda TW, et al: Verfahren 
zum Herstellen von Zellulosefaseru und diese enthaltendes Fil- 
ter. DE Patent 3.734.170, 1989 
75. Pall DB: Device and method for depletion of the leuko- 
cyte content of blood and blood components. EP Patent Appl 
0.313.348, 1987 
76. Watanabe H, Rikumaru H: Filtering unit for removing 
leukocytes. EP Patent Appl 0.155.003, 1985 
77. Nishimura T, Kuroda T, Umegae M, et al: A trial of 
leukocyte removal without platelet loss. Transactions of the 
Third World Biomaterials Congress, Kyoto, Japan, 1988, pp 
481 (abstr) 
78. Kickler TS, Bell W, Ness PM, et al: Depletion of white 
cells from platelet concentrates with a new adsorption filter. 
Transfusion 29:411-414, 1989 
79. B6ck M, Wagner M, Kniippel W, et al: Preparation of 
white cell-depleted blood---Comparison f two bedside filter 
systems. Transfusion 30:26-29, 1990 
80. Sadoff BJ, Stromberg RR, Friedman LI: Six logl0 
leuko-depletion red cell filters, in Abstracts of Papers to be 
Presented at the International Society of Blood Transfusion/ 
American Association of Blood Banks Joint Congress. Arling- 
ton, VA, American Association of Blood Banks, 1990, pp 9 
(abstr) 
81. Snyder EL, DePalma L, Napychank P: Use of polyester 
filters for the preparation of leukocyte-poor platelet concen- 
trates. Vox Sang 54:21-23, 1988 
82. Alt C: Filtration, in Ullmann Encyklop~idie der Techni- 
schen Chemie. Band 2. Verfahrenstechnik I. Weinheim, Verlag 
Chemie, 1972, pp 154-198 
83. Cain CW: Filtration theory, in Schweitzer PA (ed): 
Handbook of Separation Techniques for Chemical Engineering. 
New York, NY, McGraw-Hill, 1988, pp 4.3-4.8 
84. Tien C, Payatakes AC: Advances in deep bed filtration. 
A1ChE J 25:737-759, 1979 
85. Fiore JV, Olson WP, Hoist SL: Depth filtration, in Curl- 
ing JM (ed): Methods of Plasma Protein Fractionation. London, 
England, Academic Press, 1980, pp 239-268 
86. Herzig JP, LeClerc DM, le Goff P: Flow of suspensions 
through porous media--Application to deep filtration. Ind Eng 
Chem 62:8-35, 1970 
87. Ives KJ: Depth filtration of liquids. Filtr Separ 7:700- 
704, 1970 
88. Ramarao BV, Chien C: Stochastic simulation of aerosol 
deposition i  model filters. A1ChE J 34:253-262, 1988 
89. Brock TD: Membrane structure and functioning, in 
Brock TD (ed): Membrane Filtration. Berlin, Germany, Spring 
Verlag, 1983, pp 5-25 
90. Mutharasan R, Apelian D, Romanowski C: A laboratory 
investigation of aluminum filtration through deep-bed and ce- 
ramic open-pore filters. J Metals 33:12-18, 1981 
91. Conti C, Jacob M: Depth filtration of liquid metals: Ap- 
plication of the limiting trajectory method to the calculation 
inclusion deposition in open cell structure filters. Bull Soc 
China France 1984:1.297-1.313, 1984 
92. Netter P, Conti C: Efficiency of industrial filters for 
molten metal treatment evaluation of a filtration process model. 
Light Metals 2:847-860, 1986 
93. Ives KJ: Capture mechanisms in filtration, in lves KJ 
(ed): The Scientific Basis of Filtration. Leiden, The Nether- 
lands, Noordhoff, 1975, pp 183-202 
94. Heertjes PM, Zuideveld PL: Clarification of liquids us- 
ing filter aids--Part II--Depth filtration. Powder Technol 19: 
31-43, 1978 
95. Tsurumi T, Osawa N, Hirasaki T, et al: Mechanism of 
removing monodisperse gold particles from a suspension using 
cuprammonium regenerated cellulose hollow fiber (BMM hol- 
low fiber). Polymer J 22:304-31 l, 1990 
96. Trenor AIJ: Recent developments in depth filtration. 
Process Biochem 11:34-37, 1976 
97. Schmalzer EA, Skalak R, Usami S, et al: Influence of 
red cell concentration  filtration of blood cell suspensions. 
Biorheology 20:29-40, 1983 
98. Zaiss S: The influence of calcium on the deformability 
of human granulocytes. Biorheology 27:701-709, 1990 
99. Lucas GS, Caldwell NM, Kenny MW, et al: Effect of 
calcium-chelating and non-chelating anticoagulants onerythro- 
cyte and leukocyte filterability. Clin Hemorheol 3:451-467, 
1983 
100. Blackshear PL, Anderson RJ: Hemolysis thresholds in
microporous tructures. Blood Cells 3:377-395, 1977 
101. Blackshear PL, Christianson TJ, Majerle ILl, et al: Re- 
sistance of erythrocyte flow into pores. J Rheol 23:681-702, 
1979 
102. Skalak R, Impelluso T, Schmalzer EA, et al: Theoret- 
ical modeling of filtration of blood cell suspensions. Biorheol- 
ogy 20:41-56, 1983 
103. Skalak R, Soslowsky L, Schmalzer E, et al: Theory of 
filtration of mixed blood cell suspensions. Biorheology 24:35- 
52, 1987 
104. Bruil A, van Aken WG, Beugeling T, et al: Asymmet- 
ric membrane filters for the removal of leukocytes from blood. 
J Biomed Mater Res 25:1459-1480, 1991 
105. Bruil A, Feijen J: Asymmetric membrane filters to re- 
move leukocyte (WBC) from blood, in Abstracts of Papers 
Presented at the International Society of Blood Transfusion/ 
American Association of Blood Banks Joint Congress. Arling- 
ton, VA, American Association of Blood Banks, 1990, pp 6 
(abstr) 
106. Callaerts AJ, Gielis ML, Sprengers ED, et al: The 
mechanism ofwhite cell reduction by synthetic fiber cell filters. 
Transfusion 33:134-138, 1993 
107. Schmid-Sch6nbein GW, Usami S, Skalak R, et al: The 
interaction of leukocytes and erythrocytes incapillary and post- 
capillary vessels. Microvasc Res 19:45-70, 1980 
108. Schmid-Sch6nbein GW, Skalak R, Usami S, et al: Cell 
distribution in capillary networks. Microvasc Res 19:18-44, 
1980 
109. Fenton BM, Can" RT, Cokelet GR: Nonuniform red 
cell distribution i  20 to 100 p,m bifurcations. Microvasc Res 
29:103-126, 1985 
110. Oshima N, Sato M, Oda N: Microhemodynamics of 
blood flow in narrow glass capillaries of 9 to 20 micrometers; 
the Fahraeus effect. Biorheology 25:339-348, 1988 
LEUKOCYTE REMOVAL BY FILTRATION 
111. Goldsmith HL, Spain S: Margination of leukocytes in 
blood flow through small tubes. Microvasc Res 27:204-222, 
1984 
112. Nobis U, Pries AR, Cokelet GR, et al: Radial distri- 
bution of white cells during blood flow in small tubes. Mi- 
crovasc Res 29:295-304, 1985 
113. Mayrovitz HN, Kang SJ, Herscovici B, et al: Leuko- 
cyte adherence initiation in skeletal muscle capillaries and ve- 
nules. Microvasc Res 33:22-34, 1987 
114. Crumpton MJ, Owens RJ, Callagher CJ, et al: The cell 
surface and its metabolism. J Pathol 141:235-248, 1983 
115. Hudson L: Lymphocytes, receptors and affinity chro- 
matography. J Chromatogr 159:123-128, 1978 
116. Aplin JD, Hughes RC: Cell adhesion on model sub- 
strata: Threshold effects and receptor modulation. J Cell Sci 
50:89-103, 1981 
117. Randall RE: Preparation and uses of immunoabsorbent 
monolayers in the purification of virus proteins and separation 
of cells on the basis of their surface antigens. J Immunol Meth 
60:147-165, 1983 
118. Springer TA, Miller LJ, Anderson DC: p150,95, The 
third member of the Mac-l, LFA-1 human leukocyte adhesion 
glycoprotein family. J Immunol 136:240-245, 1986 
119. Anderson DC, Springer TA: Leukocyte adhesion defi- 
ciency: An inherited efect in the Mac-l, LFA-1 and p150,95 
glycoproteins. Ann Rev Med 38:175-194, 1987 
120. Kishimoto TK, Hollander N, Roberts TM, et al: Het- 
erogenous mutations in the 13 subunit common to the LFA-1, 
Mac-l, and p150,95 glycoproteins cause leukocyte adhesion 
deficiency. Cell 50:193-202, 1987 
121. Takemoto Y, Matsuda T, Kishimoto T, et al: Molec- 
ular understanding of cellular adhesion on artificial surfaces. 
Trans Am Soc Artif Intern Organs 35:354-356, 1989 
122. Ito Y, Kajihara M, Imansishi Y: Materials for enhanc- 
ing cell adhesion by immobilization of cell adhesive peptide. J 
Biomed Mater Res 25:1325-1337, 1991 
123. Sharma SK, Mahendroo PP: Affinity chromatography 
of cells and cell membranes. J Chromatogr 184:471-499, 1980 
124. Hertz CM, Graves DJ, Lauffenberger DA, et al: Use of 
cell affinity chromatography forseparation of lymphocyte sub- 
populations. Biotech Bioeng 27:603-612, 1985 
125. Curtis ASG, Forrester JV, Mclnnes C, et al: Adhesion 
of cells to polystyrene surfaces. J Cell Bio197:1500-1506, 1983 
126. Curtis ASG, Forrester JV: The competitive ffects of 
serum proteins on cell adhesion. J Cell Sci 71:17-35, 1984 
127. Curtis ASG, Forrester JV, Clark P: Substrate hydrox- 
ylation and cell adhesion. J Cell Sci 86:9-24, 1986 
128. Bruil A, Brenneisen LM, Terlingen JGA, et al: In vitro 
leukocyte adhesion on modified polyurethane surfaces, in 
Transactions of the Fourth World Biomaterials Congress. Ber- 
lin, Germany, 1992, p 282 (abstr) 
129. Bruil A, Terlingen JGA, Beugeling T, et al: In vitro 
leukocyte adhesion to modified polyurethane surfaces--I-- 
Effect of ionizable functional groups. Biomaterials 13:915-923, 
1992 
130. Owens NF, Gingell D, Trommler A: Cell adhesion to 
hydroxyl groups of a monolayer. J Cell Sci 91:269-279, 1988 
131. Lee JH, Park JW, Lee liB: Cell adhesion and growth 
on polymer surfaces with hydroxyl groups prepared by water 
vapour plasma treatment. Biomaterials 12:443-448, 1991 
132. Ertel SI, Chilkoti A, Horbett TA, et al: Endothelial cell 
163 
growth on oxygen-containing films deposited by radio- 
frequency plasmas: The role of surface carbonyl groups. J Bi- 
omater Sci Polymer Ed 3:163-183, 1991 
133. Kataoka K, Sakurai Y, Maruyama A, et al: Controlled 
adsorption of cells on microdomain structured polymer sur- 
faces. Polymer Mater Sci Eng 53:37-41, 1985 
134. Srinivasan S, Sawyer PN: Correlation of the surface 
charge characteristics of polymers and their antithrombogenic 
characteristics, in Rembaum A, Shen M (eds): Biomedical 
Polymers. New York, NY, Dekker, 1971, pp 51-66 
135. Klemperer HG, Knox P: Attachment and growth of 
BHK cells and liver cells on polystyrene: Effect of surface 
groups introduced by treatment with chromic acid. Lab Pract 
26:179-180, 1977 
136. Grasel TG, Cooper SL: Properties and biological inter- 
actions of polyurethane anionomers: Effect of sulphonate in- 
corporation. J Biomed Mater Res 23:311-338, 1989 
137. Ramsey WS, Hertl W, Nowlan ED, et al: Surface treat- 
ments and cell attachments. In Vitro 20:802-808, 1984 
138. Gingell D, Vince S: Long-range forces and adhesion: 
An analysis of cell-substratum studies, in Curtis ASG, Pitts JD 
(eds): Cell Adhesion and Motility. Cambridge, England, Uni- 
versity Press, 1980, pp 1-38 
139. Bruil A, Oosterom HA, Steneker I, et al: Poly(ethyle- 
neimine) modified filters for the removal of leukocytes from 
blood. J Biomed Mater Res 27:1253-1268, 1993 
140. Ballard CM, Roberts MHW, Dickinson JP: Cell sur- 
face charge~orrelation of partition with electrophoresis. Bio- 
chim Biophys Acta 582:102-106, 1979 
141. van Oss CJ, Gillman CF, Neumann AW: Phagocytic 
Engulfment and Cell Adhesiveness as Cellular Surface Phe- 
nomena. New York, NY, Dekker, 1975 
142. Vassar PS, Hards JM, Seaman GVF: Surface proper- 
ties of human lymphocytes. Biochim Biophys Acta 291:107- 
115, 1973 
143. Sherbet GV, Lakshmi MS, Rao KV: Characterisation 
of ionogenic groups and estimation of the net negative lectric 
charge on the surface of cells using natural pH gradients. Exp 
Cell Res 70:113-123, 1972 
144. Curtis ASG: Cell adhesion. Progr Biophys Mol Biol 
27:317-375, 1973 
145. Harkes G, Feijen J, Dankert J: Adhesion of Escheri- 
chin coil on to a series of poly(methacrylates) differing in 
charge and hydrophobicity. Biomaterials 12:853-860, 1991 
146. Gingell D, Todd I: Adhesion of red blood cells to 
charged interfaces between immiscible liquids--A new 
method. J Cell Sci 18:227-239, 1975 
147. Moroson H, Rotman M: Biomedical applications of 
polycations, in Rembaum A, Selegny E (eds): Polyelectrolytes 
and Their Applications. Dordrecht, The Netherlands, Reidel, 
1975, pp 187-195 
148. Tetta C, Segoloni G, Camussi G, et al: In vitro com- 
plement-dependent activation of human neutrophils by bemo- 
dialysis membranes; role of the net electric harge. Int J Artif 
Organs 10:83-88, 1987 
149. Dolowy K: A physical theory of cell-cell and cell- 
substratum interactions, in Curtis ASG, Pitts JD (eds): Cell 
Adhesion and Motility. Cambridge, England, University Press, 
1980, pp 39-64 
150. Srinivasan R, Ruckenstein E: Kinetically caused satu- 
164 BRUIL ET AL 
ration in the deposition of particles or cells. J Colloid Interface 
Sci 79:390-398, 1981 
151. Polliack A, Lampen N, Clarkson BD, et al: Identifica- 
tion of human B and T lymphocytes by scanning electron mi- 
croscopy. J Exp Med 138:607-624, 1973 
152. Groth T, Klosz K, Strietzel F: Die H/imokompatibilit~it 
von Polyurethanen--II---Untersuchung der in vitro H/imo- 
kompatibilit~t. Z Biomed Technik 36:324-325, 1991 
153. Bruil A, Brenneisen LM, Terlingen JGA, et al: In vitro 
leukocyte adhesion to modified polyurethane surfaces--II-- 
Effect of wettability. J Colloid Interface Sci 165:72-81, 1994 
154. Lim F, Cooper SL: The effect of surface hydrophilicity 
on biomaterial-leukocyte int ractions. Am Soc Artif Intern Or- 
gans Trans 37:M146-M147, 1991 
155. van Kampen CL, Gibbons DF, Jones RD: Effect of 
implant surface chemistry upon arterial thrombosis. J Biomed 
Mater Res 13:517-541, 1979 
156. Halperin G, Tauber-Finkelstein M, Shaltiel S: Hydro- 
phobic chromatography of cells; adsorption and resolution on 
homologous eries of alkylagaroses. J Chromatography 317: 
103-118, 1984 
157. Matsumoto U, Shibusawa Y: Surface affinity chro- 
matographic separation of blood cells--V--Retention behav- 
iour of human peripheral blood cells on poly(propylene glycol) 
bonded agarose columns and its relationship to surface hydro- 
phobicities of the gel beads and the cells. J Chromatogr 356: 
27-36, 1986 
158. Neumann AW, Absolom DR, van Oss CJ, et al: Sur- 
face thermodynamics of leukocyte and platelet adhesion to 
polymer surfaces. Cell Biophys 1:79-92, 1979 
159. Absolom DR, Thomson C, Hawthorn LA, et al: Ki- 
netics of cell adhesion to polymer surfaces. J Biomed Mater 
Res 22:215-229, 1988 
160. Neumann AW, Absolom DR, Francis DW, et al: Con- 
version tables of contact angles to surface tensions. Separation 
Purification Sci 9:69-163, 1980 
161. Neumann AW, Hum OS, Francis DW, et al: Kinetic 
and thermodynamic aspects of platelet adhesion from suspen- 
sion to various substrates. J Biomed Mater Res 14:499-509, 
1980 
162. Absolom DR, Neumann W: Adhesion of hydrophilic 
particles to polymer substrates immersed in aqueous media. J
Adhesion 22:329-355, 1987 
163. Absolom DR, Snyder EL: Role of filter surface tension 
in the retention of cellular elements by microaggregate blood 
filters. J Disp Sci Technol 6:37-53, 1985 
164. Kataoka K, Okano T, Sakurai Y, et al: Differential 
retention of lymphocyte subpopulations (B and T cells) on the 
microphase separated surface of polystyrene/polyamine graft 
copolymers. Eur Pol Sci 19:979-984, 1983 
165. Maruyama A, Tseruta T, Kataoka K, et al: Polyamine 
graft copolymer for separation of rat B and T lymphocytes-- 
Role of ionic interaction between polymer matrix and lympho- 
cytes. Makromol Chem Rapid Comm 8:27-30, 1987 
166. Okano T, Nishiyama S, Shinohara I, et al: Effect of 
hydrophilic and hydrophobic microdomains on mode of inter- 
action between block polymer and blood platelets. J Biomed 
Mater Res 15:393-402, 1981 
167. Okano T, Aoyagi T, Kataoka K, et al: Hydrophilic- 
hydrophobic microdomain surfaces having an ability to sup- 
press platelet aggregation and their in vitro antithrombogenic- 
ity. J Biomed Mater Res 20:919-927, 1986 
168. Yui N, Sanui K, Ogata N, et al: Effect of crystallinity 
of polyamides on adhesion-separation of granulocytes. J 
Biomed Mater Res 17:383-388, 1983 
169. Yui N, Sanui K, Ogata N, et al: Effect of microstruc- 
ture of poly(propylene-oxide)-segmented polyamides on plate- 
let adhesion. J Biomed Mater Res 20:929-943, 1986 
170. Okano T, Nishiyama S, Shinohara I: Interaction of 
plasma protein and microphase separated structure of copoly- 
mers. Polymer J 10:223-228, 1978 
171. Takahara A, Tashita J, Kajiyama T, et al: Microphase 
separated structure and blood compatibility of segmented poly- 
(urethaneureas) with different diamines in the hard segment. 
Polymer 26:978-986, 1985 
172. Castner DG, Ratner BD, Hofman AS: Surface charac- 
terization of a series of polyurethanes by x-ray photoelectron 
spectroscopy and contact angle methods. J Biomed Sci Polymer 
Edn 1:191-206, 1990 
173. Predecki P, Life L, Newman MM: Prevention of plate- 
let adhesion to porous surfaces. J Biomed Mater Res 14:405- 
415, 1980 
174. Clarke DR, Park JB: Prevention of erythrocyte adhe- 
sion onto porous urfaces by fluid perfusion. Biomateriais 2:% 
13, 1981 
175. von Recum AF: New aspects of biocompatibility: Mo- 
tion at the interface, in Heirnke G, Solt6sz U, Lee AJC (eds): 
Clinical Implant Materials. Amsterdam, The Netherlands, 
Elsevier, 1990, pp 297-302 
176. Chang G, Absolom DR, Strong AB, et al: Physical and 
hydrodynamic factors affecting erythrocyte adhesion to poly- 
mer surfaces. J Biomed Mater Res 12:13-29, 1988 
177. RichA, Harris AK: Anomalous preferences ofcultured 
macrophages for hydrophobic and roughened substrata. J Cell 
Sci 50:1-7, 1980 
178. Zingg W, Neumann AW, Strong AB: Platelet adhesion 
to smooth and rough hydrophobic and hydrophilic surfaces un- 
der conditions of static exposure and laminar flow. Biomateri- 
als 2:156-158, 1981 
179. Ward CA, Ruegsegger B, Stanga D, et al: Reduction in 
platelet adhesion to biomaterials by removal of gas nuclei. 
Trans Am Soc Artif Inter Organs 20:77-85, 1974 
180. Ward CA, Koheil A, Johnson WR, et al: Reduction of 
complement activation from biomaterials by removal of air nu- 
clei from the surface roughness. J Biomed Mater Res 18:255- 
269, 1984 
181. Miiller-Eberhard HJ: Molecular organisation and func- 
tion of the complement system. Ann Rev Biochem 57:321-347, 
1988 
182. Goldstein IM: Complement; biologically active prod- 
ucts, in GaUin JI, Goldstein IM, Snyderman R (eds): Basic 
Principles and Clinical Correlates. New York, NY, Raven, 
1988, pp 55-74 
183. Kazatchkine MD, Carreno MP: Activation of the com- 
plement system at the interface between blood artificial sur- 
faces. Biomaterials 9:30-35, 1988 
184. Hed J, Johansson M, Lindroth M: Complement activa- 
tion according to the alternative pathway by glass and plastic 
and its role in neutrophil adhesion. Immunol Lett 8:295-299, 
1984 
185. Herzlinger GA, Cumming RD: Role of complement 
LEUKOCYTE REMOVAL BY FILTRATION 165 
activation in cell adhesion to polymer blood contact surfaces. 
Trans Am Soc Artif Intern Organs 26:165-171, 1980 
186. Payne MS, Horbett TA: Complement activation by hy- 
droxyethylmethacrylate-ethylmethacrylate copolymers. J 
Biomed Mater Res 21:843-859, 1987 
187. Kottke-Marchant K, Anderson JM, Miller KM, et al: 
Vascular graft-associated complement activation and leukocyte 
adhesion in an artificial circulation. J Biomed Mater Res 21: 
379-397, 1987 
188. Sevast'ianov VI, Tseytlina EA: The activation of the 
complement system by polymer materials and their blood com- 
patibility. J Biomed Mater Res 18:969-978, 1984 
189. Chenoweth DE: Complement activation produced by 
biomaterials, inHering M, Glover JL (eds): Endothelial Seed- 
ing in Vascular Surgery. Orlando, FL, Grune & Stratton, 1987, 
pp 139-153 
190. Uchida T, Hosaka S, Murao Y: Complement activation 
by polymer binding IgG. Biomaterials 5:281-283, 1984 
191. Lelah M, Johnson R, Chenoweth D, etal: Complement 
activation of ionic polyurethanes, in Transactions of the Third 
World Biomaterials Congress. Kyoto, Japan, 1988, p 526 (ab- 
str) 
192. Law SK, Minich TM, Levine RP: Binding reaction 
between the third human complement protein and small mole- 
cules. Biochemistry 20:7457-7463, 1981 
193. Carreno MP, Labarre D, Josefowics M, et al: The abil- 
ity of sephadex to activate human complement is suppressed in 
specifically substituted functional sephadex derivatives. Mol 
Immunol 25:165-171, 1988 
194. Vanherweghem JL, Drnkker W, Schwarz A: Clinical 
significance of blood-device interaction i hemodialysis--A re- 
view. Int J Artif Organs 10:219-232, 1987 
195. Breillat J, Dorson WJ: Hemocompatibility studies. 
Quantification of serum complement activation by polymeric 
membranes and materials. Am Soc Artif Intern Organs J 7:57- 
63, 1984 
196. Kayashima K, Asanuma Y, Smith JW, et al: Simple 
on-line filters for the therapeutic removal of lymphocytes from 
blood. Trans Am Soc Artif Intern Organs 27:559-562, 1981 
197. Jungi TW: Evaluation of various filter membranes for 
byden-type l ukocyte migration studies. J Immunol Meth 21: 
373-382, 1978 
198. Takaoka T, Goldcamp JB, Abe Y, et al: Biocompati- 
bility of membrane plasma separation. Trans Am Soc Artif 
Intern Organs 30:347-352, 1984 
199. Spilizewski KL, Marchant RE, Anderson JM, et al: In 
vivo leukocyte interactions with NHLBI-DTB primary refer- 
ence materials; polyethylene and silica-free polydimethylsilox- 
ane. Biomaterials 8:12-17, 1987 
200. Marchant RE, Anderson JM, Dillingham EO: In vivo 
biocompatibility studies--VII--Inflammatory response to 
polyethylene and to a cytotoxic polyvinylchloride. J Biomed 
Mater Res 20:37-50, 1986 
201. Unarska M, Robinson GB: Adherence of human leu- 
kocytes to synthetic polymer surfaces. Life Supp Syst 5:283- 
292, 1987 
202. Shepard AD, Gelfand JA, Callow AD, et al: Comple- 
ment activation by synthetic vascular prosthesis. J Vasc Surg 
1:829-838, 1984 
203. Kataoka K, Maeda M, Nishimura T, et al: Estimation 
of cell adhesion on polymer surfaces with the use of the 'col- 
umn-method.' J Biomed Mater Res 14:817-823, 1980 
204. Ikeda Y, Kohjiya S, Yamashita S, et al: Activation of 
the complement system in blood on the surface of segmented 
polyurethaneurea having good blood compatibilities. Polymer J 
20:273-276, 1988 
205. Matsuda T, Kondo A, Makino K, et al: Development 
of a novel artificial matrix with cell adhesion peptides for cell 
culture and artificial and hybrid organs. Trans Am Soc Artif 
Intern Organs 35:677-679, 1989 
206. Vroman L, Adams AL: Why plasma proteins interact at 
surfaces. Am Chem Soc Symp Series 343:154-164, 1987 
207. Bale MD, Mosher DF, Wolfarht L, et al: Competitive 
adsorption of fibronectin, fibrinogen, immunoglobulin, albu- 
min, and bulk plasma proteins on polystyrene latex. J Colloid 
Interface Sci 125:516-525, 1988 
208. Elwing H, Askendal A, Lundstrrm I: Competition be- 
tween adsorbed fibrinogen and high-molecular-weight kinino- 
gen on solid surfaces incubated in human plasma (the Vroman 
effect); influence of solid surface wettability. J Biomed Mater 
Res 21:1023-1028, 1987 
209. van Damme H: Protein Adsorption at Solid-Liquid In- 
terfaces. Enschede, FEBO-druk, thesis University of Twente, 
The Netherlands, 1990 
210. Dekker A, Reitsma K, Beugeling T, et al: Adhesion of 
endothelial cells and adsorption of serum proteins on gas 
plasma-treated polytetrafluoroethylene. Biomaterials 12:130- 
138, 1991 
211. Horbett TA: Adsorption of proteins from plasma to a 
series of hydrophilic-hydrophobic copolymers-- I I - -  
Compositional nalysis with the prelabeled protein technique. J 
Biomed Mater Res 15:673-695, 1981 
212. Absolom DR, Zingg W, Neumann AW: Protein ad- 
sorption to polymer particles; role of surface properties. J 
Biomed Mater Res 21:161-171, 1987 
213. Cheng YL, Darst SA, Robertson CR: Bovine serum 
albumin adsorption and desorption rates on solid surfaces with 
varying surface properties. J Colloid Interface Sci 118:212-223, 
1987 
214. Barber TA, Lambrecht LK, Mosber DL, et al: Influ- 
ence of serum proteins on thrombosis and leukocyte adherence 
on polymer surfaces. Scan Electron Microsc 3:881-890, 1979 
215. Forrester JV, Lackie JM: Adhesion of neutrophil leu- 
kocytes under conditions of flow. J Cell Sci 87:93-110, 1984 
216. Grinnell F, Feld MK: Adsorption characteristics of
plasma fibronectin in relationship to biological activity. J 
Biomed Mater Res 15:363-381, 981 
217. Garcia-Pardo A, Ferreira OC: Adhesion of human 
T-lymphoid cells to fibronectin is mediated by two different 
fibronectin domains. Immunology 69:121-126, 1990 
218. Curtis ASG: Cell activation and adhesion. J Cell Sci 
87:609-611, 1987 
219. Hynes RO: Fibronectins. Scientific American 254:32- 
41, 1986 
220. Hoffstein ST, Weissmann G, Pearlstein E: Fibronectin 
is a component of the surface coat of human eutrophil. J Cell 
Biol 50:315-327, 1981 
221. Klebe RJ, Bentley KL, Schoen RC: Adhesive sub- 
strates for fibronectin. J Cell Physiol 109:481-488, 1981 
222. Pierschbacher MD, Ruoslahti E: Cell attachment activ- 
166 BRUIL ET AL 
ity of fibronectin can be duplicated by small synthetic frag- 
ments of the molecule. Nature 309:30-33, 1984 
223. Brown EJ, Goodwin JL: Fibronectin receptors of mac- 
rophages~haracterization of the Arg-Gly-Asp binding pro- 
teins of human monocytes and polymorphonuclear leukocytes. 
J Exp Med 167:777-793, 1988 
224. Bruil A, Sheppard JI, Feijen J, et al: In vitro leukocyte 
adhesion to modified polyurethane surfaces--Ill--Effect of 
flow, fluid medium, and platelets on PMN adhesion. J Biomat 
Sci Pol Ed 5:263-277, 1994 
225. Shimizu T, Mizuno S, Yamaguchi H, et al: Filtration 
through a polyester white cell-reduction filter of plasma-poor 
platelet concentrates prepared with an acetate-containing addi- 
tive solution. Transfusion 33:730-734, 1993 
226. Rasp FL, Clawson CC, Repine JE: Platelets increase 
neutrophil adherence in vitro to nylon fiber. J Lab Clin Med 
97:812-819, 1981 
227. Morley DJ, Feuerstein IA: Adhesion of polymorpho- 
nuclear leukocytes to protein-coated and platelet adherent sur- 
faces. Thromb Haemost 62:1023-1028, 1989 
228. Steneker I, Prins HK, Florie M, et al: Mechanisms of 
white cell reduction in red cell concentrates byfiltration. The 
effect of the cellular composition of the red cell concentrates. 
Transfusion 32:42-50, 1992 
229. Larson E, Cell A, Gilbert GE, et al: PADGEM protein; 
a receptor that mediates the interaction of activated platelets 
with neutrophils and monocytes. Cell 59:305-312, 1989 
230. Hamburger SA, McEver RP: GMP-140 mediates ad- 
hesion of stimulated platelets to neutrophils. Blood 75:550-554, 
1990 
231. Yeo EL, Kennington J, Feuerstein IA: Role of PAD- 
GEM/GMP-140 in leukocyte-adherent platelet interaction un- 
der flow conditions. Blood 78:278, 1991 (suppl 1; abstr 1104) 
232. Faint RW: Platelet-neutrophil interactions: Their sig- 
nificance. Blood Rev 6:83-91, 1992 
233. Steneker I, van Luyn MJA, van Wachem PB, et al: 
Electronmicroscopic examination of white cell depletion on 
four leukocyte depletion filters. Transfusion 32:450-457, 1992 
234. Kvarstein B: Effects of proteins and inorganic ions on 
the adhesiveness of human leukocytes to glass beads. Scand J
Clin Lab Invest 24:41-48, 1969 
235. Hoover RL, Folger R, Hearing WA, et ah Adhesion of 
leukocytes to endothelium: Roles of divalent cations, surface 
charge, chemotactic agents and substrate. J Cell Sci 45:73-86, 
1980 
236. Lang EV, Lang JH, Lasser EC: Adherence of granu- 
locytes to nylon fibers--Evidence for a plasma granulocyte 
adherence factor. Thromb Res 50:243-248, 1988 
237. Diepenhorst P: Removal of leukocytes from whole 
blood and erythrocyte suspensions by filtration through cotton 
wool~VlI~tudies onpossible mechanisms, in Diepenhorst 
P: Removal of Leukocytes From Blood by Filtration Through 
Cotton Wool. Meppel, Krips, thesis Delft University of Tech- 
nology, The Netherlands, 1974, pp 86-90 
238. Prins HK, Steneker I: Statistic simulation of leukocyte 
depletion by filtration with the aid of a computer model, in 
Steneker I: Leukocyte Depletion From Fresh Red Cell Concen- 
trates by Fiber Filtration. Amsterdam, VU University Press, 
thesis Free University of Amsterdam, The Netherlands, 1992, 
pp 97-109 
239. Mackie RI: Rapid gravity filtration--Towards a deeper 
understanding. Filtration Separation 26:32-35, 1989 
240. Vigneswaran S, Tulachan RK: Mathematical model- 
ling of transient behaviour of deep bed filtration. Water Res 
22:1093-1100, 1988 
241. Matharasan R, Apelian D, Romanowski C: Laboratory 
investigation of aluminum filtration through deep-bed and ce- 
ramic open-pore filters. J Metals 33:12-18, 1981 
242. Adin A, Rebhun M: Deep-bed filtration; accumulation- 
detachment model parameters. Chem Eng Sci 42:1213-1219, 
1987 
243. Bruil A, Beugeling T, Feijen J: A mathematical model 
for the leukocyte filtration process, in Bruil A (ed): Leukocyte 
Filters. Thesis, University Twente, Enschede, The Nether- 
lands, 1993, pp 159-172 
244. Ives KJ: Mathematical models of deep bed filtration, in 
Ives KJ (ed): The Scientific Basis of Filtration. Leiden, The 
Netherlands, Noordhoff, 1975, pp 203-224 
245. Iwasaki T: Some notes on sand filtration. J Am Water 
Works Assoc 29:1591-1602, 1937 
246. Mackrle V, Mackrle S: Adhesion in filters. J Sanit Eng 
Div Proc Am Soc Civil Eng SA5:17-32, 1961 
